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Three-dimensional (3D) bioprinting has been utilized for decades, and today its popularity is up 
surging. 3D bioprinting is based on the use of the natural, non-toxic, and tissue-mimicking bio-
materials which are extruded in the form of bioinks to generate different structures layer-by-layer, 
from a simple cylinder to the shape of an ear. This method is gaining popularity in the field of re-
generative medicine in which the focus is in regenerating and replacing injured tissues and organs. 
However, the major obstacles in the utilization of the current biomaterials are their insufficient 
properties, especially in the case of the mechanical strength. Therefore, new materials, hybrid ma-
terials, and material composites need to be developed.     
 
In this Master’s thesis, the novel CLP-CNF-alginate bioink compositions were prepared with the cel-
lulose nanofibril (CNF) concentrations of 2.5 wt%, alginate concentrations of 0.5 wt%, and colloidal 
lignin nanoparticle (CLP) concentrations relative to the dry weight of CNF. The rheological proper-
ties of these bioinks were measured through the dynamic viscosity and amplitude sweep measure-
ments, whereas the printability of the bioinks was tested in 3D bioprinting. This was followed by 
the compression tests and the evaluation of the hydrogels in different storage conditions. These 
various stability tests included freeze-drying, re-wetting, humidity chamber, salt-water solution, 
and free-standing at room temperature.       
 
The addition of CLPs into the CNF-alginate hydrogel offered many advantages. Most importantly, 
the existence of CLPs enhanced the printability and structural stability of the hydrogels directly after 
3D bioprinting. On the other hand, the addition of CLPs increased the dimensional stability of the 
CLP-CNF-alginate hydrogels in high humidity and salt-water solutions. Nevertheless, dissolution in 
the salt-water solution, fast drying in the room air, and the non-toxicity of these hydrogels with the 
degradation rates inside the human body require further research. However, these multiple intrin-
sic properties of the CLP-CNF-alginate hydrogels make them a multifunctional material for the re-
generative medicine.      
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3D-bioprinttausta on hyödynnetty vuosikymmeniä, mutta nykyään sen suosio on räjähdysmäisessä 
kasvussa. 3D-bioprinttauksessa käytetään luonnonmukaisia, myrkyttömiä ja kudoksia jäljitteleviä 
biomateriaaleja, jotka ruiskutetaan biotahnojen muodossa, kerros kerrokselta, muodostamaan eri-
laisia rakenteita, aina yksinkertaisesta lieriöstä korvanmuotoisiin rakenteisiin asti. Menetelmä on 
suosittu regeneroivassa lääketieteessä, jossa keskitytään vahingoittuneiden tai sairaiden kudosten 
sekä elinten korvaamiseen. Suurimmat haasteet nykyisten biomateriaalien hyödyntämisessä liitty-
vät niiden riittämättömiin ominaisuuksiin, erityisesti mekaanisten ominaisuuksien osalta. Tämän 
vuoksi uusia materiaaleja, hybridimateriaaleja ja materiaalikomposiitteja on tärkeä kehittää.  
 
Tässä diplomityössä valmistettiin uusia CLP-CNF-alginaatti -biotahnoja, jotka sisälsivät 2,5 p-% na-
nofibrilloitua selluloosaa (CNF), 0,5 p-% alginaattia ja kolloidisia ligniinipartikkeleita (CLPs) CNF-kui-
tujen kuivapainon mukaisesti. CLP-CNF-alginaatti -biotahnojen reologiset ominaisuudet mitattiin 
dynaamisten viskositeetti- ja amplitudimittausten avulla. Biotahnojen printattavuutta sen sijaan 
tutkittiin 3D bioprinttauksessa, mitä seurasivat kompressiotestit ja varastointimittaukset. Varas-
tointimittauksiin kuuluivat hydrogeelien kylmäkuivaus, uudelleen kostutus sekä säilytys kosteus-
kammiossa, suolavesiliuoksessa ja huoneilmassa.     
 
Ligniinipartikkeleiden lisäys CNF-alginaatti -hydrogeeliin tarjosi monia etuja. Ligniinipartikkelit pa-
ransivat erityisesti hydrogeelien printattavuutta sekä rakenteen stabiilisuutta 3D bioprinttauksen 
jälkeen. Ligniinipartikkeleiden lisäys kasvatti myös hydrogeelien rakenteellista pysyvyyttä korke-
assa kosteudessa ja suolaliuoksessa. Hydrogeelien liukeneminen suolaliuoksessa, nopea kuivumi-
nen huoneilmassa sekä myrkytön hajoaminen elimistössä vaativat kuitenkin lisätutkimusta. Ylei-
sesti ottaen CLP-CNF-alginaatti -hydrogeelit ovat monikäyttöisiä materiaaleja regeneroivan lääke-
tieteen tarkoituksiin.         
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INTRODUCTION  
3D printing has been an emerging technology worldwide, offering many possibilities 
in different industries. In the past few decades, also 3D bioprinting has gained more 
and more popularity and has became one of the promising technologies for example 
in medicine (Zhang et al., 2018). This is due to the few main properties related to the 
3D bioprinting, which are bio-based and thus biocompatible materials used in 3D 
bioprinting, and possibility to distribute cells, biochemical factors, proteins, and drugs 
at the desired locations (Zhang et al., 2018; Francis & Bulletin, 2015; Piras et al., 
2017). Due to these many benefits of 3D bioprinting, it has became a promising 
method for regenerative medicine (Zhang et al., 2018; Savage, 2016). 3D bioprinting 
could be used for example to cut organ shortage which is inevitable because of the 
aging population worldwide (Peloso et al., 2016; Radenkovic, Soulouk, & Seifalian, 
2016).       
The different main technologies of 3D bioprinting are inkjet bioprinting, extrusion 
bioprinting and laser-assisted bioprinting. Inkjet bioprinters use thermal or acoustic 
forces to eject drops of liquid onto a substrate (Dzobo et al., 2018; Murphy & Atala, 
2014), whereas extrusion-based bioprinters use an air-forced pump, a mechanical 
screw, or a plunger (Dzobo et al., 2018; Mandrycky et al., 2016). On the other hand, 
laser-assisted bioprinters are based on the laser pulse which vaporizes a portion of 
the donor layer, creating a high pressure bubble at the interface of the bioink (Dzobo 
et al., 2018; Mandrycky et al., 2016; Murphy & Atala, 2014). A recent, competitive 3D 
bioprinting technology is strereolithography bioprinting which is based on the 
polymerization by UV light, near-UV blue light, or visible light, utilizing the digital 
mirror arrays (Wang et al., 2015; Wang et al., 2018).  
These 3D bioprinting types have different characteristics. Microextrusion can be used 
for the bioinks with the widest viscosity range, but it causes the highest cell densities, 
which in turn decreases the cell viability (Axpe & Oyen, 2016; Mandrycky et al., 2016; 
Murphy & Atala, 2014). Inkjet bioprinting offers a high printing speed and resolution, 
but it can be used only for the inks with limited viscosities (Axpe & Oyen, 2016; 
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Mandrycky et al., 2016; Ozbolat et al., 2017). In the end, laser-assisted bioprinting 
has a wide viscosity range, possibility for a high printing speed, and, most 
importantly, the lowest cell densities which results in the highest cell viability (Axpe 
& Oyen, 2016; Mandrycky et al., 2016; Murphy & Atala, 2014; Ozbolat et al., 2017). 
As a competitive technology, stereolithography bioprinting has a higher resolution, 
printing speed, and cell viability (Wang et al., 2015; Wang et al., 2018), when 
compared to the inkjet bioprinting and laser-assisted bioprinting, and overall shorter 
printing time (Wang et al., 2015). The suitable 3D bioprinting technology must be 
considered in the light of the materials used and the desired properties of the end 
application (Murphy & Atala, 2014).    
Despite the many positive factors of 3D bioprinting, it still faces multiple challenges. 
3D bioprinting utilizes the main technologies from 3D printing, but all the old 
technologies do not fit with the cell-friendly and non-toxic demands of 3D bioprinting 
(Axpe & Oyen, 2016). Other difficulties include the high costs associated with 3D 
bioprinting, the technical difficulties in mimicking the complex tissue and organ 
structures inside the human body, the translation of the 3D printed structures into 
pre-clinical and clinical use, establishing abundant cell sources, and, on the other 
hand, finding more biomaterials with desirable properties for the different functions 
in bioinks and in hydrogels (Francis & Bulletin, 2015; Radenkovic, Soulouk, & Seifalian, 
2016; Sadri-Ardekani & Atala, 2016; Sultan et al., 2017; Lee & Dai, 2017).  
Thus, one solution is to find more suitable biomaterials (Lee & Dai, 2017). A few 
common and widely researched biopolymers are, e.g., alginate, hyaluronic acid, and 
collagen (Ullah et al., 2018). Lately, also CNF and cellulose nanocrystals (CNCs) have 
gained a lot of attention due to their many good properties (Dai et al., 2019; Xu et al., 
2018). In this Master’s thesis, one biopolymer option, lignin in the form of CLPs, has 
been researched and its suitability for bioinks has been evaluated. According to the 
hypothesis, the addition of CLPs was expected to prevent hydrogel shrinking upon 
drying. Kidneys were selected as the target organ for the possible regenerative 
applications of CLP-CNF-alginate bioinks. The functional unit of the kidney is nephron 
which task is to maintain the body homeostasis by regulating the levels of fluid and 
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electrolytes, using glomerular filtration, selective tubular reabsorption, and secretion 
(Chuah & Zink, 2017; Lawrence et al., 2018; Moon et al., 2016). This Master’s thesis 
starts with the literature review, materials and methods describtion and ends with 
the results and conclusions.  
LITERATURE REVIEW  
1. Regenerative medicine   
1.1 The discipline   
Regenerative medicine (RE) is a field of science, employing both engineering and 
biology, providing novel therapies that ultimately aim to restore normal function to 
the damaged or diseased tissues and organs within the human body by replacing or 
regenerating human cells, tissues, and organs (Atala & Murphy, 2015; Dzobo et al., 
2018; Peloso et al., 2016; Sadri-Ardekani & Atala, 2016). This replacing or 
regeneration process requires cells, natural or artificial scaffold materials, growth 
factors and/or gene editing, depending on the end application type (Peloso et al., 
2016). Advances in tissue engineering (TE), cell biology, nuclear transfer, biological 
molecule discovery, and biomaterial science have led to new developments and 
options for cellular therapies, engineered tissues, and organs for the purposes of the 
regenerative medicine, also considering the techniques of cell harvest, culture, 
expansion, transplantation, and polymer design (Atala & Murphy, 2015; Sadri-
Ardekani & Atala, 2016).   
The cells used in the regenerative medicine are embryonic stem cells (ESCs), stem 
cells found in the adult tissues, and induced pluripotent stem cells (iPSCs) (Murphy & 
Atala, 2013; Peloso et al., 2016). Among these, embryonic and adult stem cells exist 
in the human body at all stages of life, however, their stemness potential decreases 
in time through senescence (Peloso et al., 2016). The highest stemness potential can 
be found in embryonic stem cells which are in the human embryos. These embryonic 
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stem cells can differentiate into any cells in the human body (Li et al., 2016; Murphy 
& Atala, 2013; Peloso et al., 2016). Adult stem cells also have an ability to 
differentiate, but only into certain cells. However, some adult stem cells can 
differentiate into cells outside their repertoire (Peloso et al., 2016). These autologous 
cells do not cause a host immune response, but have the limited regeneration 
capacity and technical restrictions considering the in vitro culture of these cells 
(Dzobo et al., 2018). Lately, through groundbreaking technology and the 
understanding of stemness, a new and potential stem cell type called iPSCs have been 
developed (Atala & Murphy, 2015; Peloso et al., 2016). They have been generated 
through somatic cell reprogramming using, e.g., retroviral and lentiviral vectors, 
therefore avoiding ethical production challenges, and have the same function as 
embryonic stem cells (Murphy & Atala, 2013; Atala & Murphy, 2015).  
Many induced pluripotent stem cells can be prepared simultaneously, which enables 
the use of this stem cell type in clinical therapies (Atala & Murphy, 2015). This is a 
benefit because ESCs have limitations regarding the clinical translation, e.g., ethical 
challenges due to the destruction of embryo during the ESC production, formation of 
special tumors called teratomas, and potential to evoke immune respone due to the 
allogeneic nature of the cell source (Murphy & Atala, 2013). Clinical translation of 
iPSCs has its own challenges, to mention a few, the potential of iPSCs to form tumors, 
difficulties in scalable iPSCs production, and patient selection for the clinical therapies 
(Li et al., 2016). However, embryonic stem cells and pluripotent stem cells are capable 
of self-renewal (Lou et al., 2014), and characterized by remarkable anti-inflammatory 
and immune-modulatory properties (Peloso et al., 2016). These good features offer 
many benefits when used in clinical therapies in the regenerative medicine.      
The subfields of regenerative medicine are cell therapy, tissue engineering and 
production of artificial organs, and regenerative pharmacology (Atala et al., 2008; 
Atala & Murphy, 2015). In cell therapy, different stem cell types are utilized in treating 
diseases, and thus, the ability to understand and efficiently control the function and 
proliferation of stem cells into specific tissues, with or without chemical inducers and 
growth factors, has been the central focus in this subfield (Atala & Murphy, 2015; 
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Kenry et al., 2018). The clinical use of bone marrow–derived stem cells to reconstitute 
the hematopoietic system acted as a start for the current cell therapy strategies in 
the 1950s, and nowadays several clinical trials are conducted (Atala & Murphy, 2015). 
On the other hand, tissue engineering aims at restoring and sustaining functions of 
diseased organs through the maximization of the innate ability of tissues to repair or 
regenerate the injury by integrating scaffolds materials with living, biological cells 
(Kenry et al., 2018; Peloso et al., 2016), or the ex vivo bio-fabrication of a diseased 
organ (Peloso et al., 2016). New approaches have been developed for this second 
subfield, recently also by decellularization (Schmitt et al., 2017), and 3D bioprinting 
(Dzobo et al., 2018), but more research is needed, especially when it comes to the 
regeneration of complex, solid organs (Savage, 2016).  
In the end, the last subfield of regenerative medicine is called regenerative 
pharmacology (Atala & Murphy, 2015). In short, this subfield studies the mechanisms, 
signaling pathways, and substrates, that mediate pluripotency and differentiation of 
various stem cells, for the therapeutic use. Traditionally, regenerative pharmacology 
utilizes expensive growth mediums, such as commercially available and popular 
mTeSR© medium (StemCell Technologies) for both ESCs and iPSCs growth and 
differentiation (Atkinson, Lako, & Armstrong, 2013). Recently, the development of 
small molecule-driven cell renewal of tissue-specific stem cells and their induction 
into a differentiated phenotype has also shown promise (Atala & Murphy, 2015; 
Atkinson, Lako, & Armstrong, 2013). These different and cost-effective small 
molecule inhibitors and activators, such as Butyryl CoA and chlorate, can boost the 
pluripotency, self-renewal, and survival of different stem cells, at the same time 
enhancing differentiation protocols (Atkinson, Lako, & Armstrong, 2013). These 
subfields of regenerative medicine are closely linked. The understanding of human 
cell function through cell therapy approaches and, on the other hand, the adequate 
tools for differentiation of the cells from regenerative pharmaceutics are essential 
parts of cell culturing and tissue and organ regeneration in tissue engineering.   
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1.2 Strategies of regenerative medicine    
The core goal of regenerative medicine is to obtain functional cells on demand for 
the lost cells due to diseases, injuries, and aging (Li et al., 2016). This requires 
advances in the understanding of stem cell differentiation, induced pluripotency, and 
the ability to directly reprogram cells into another cell type (Murphy & Atala, 2013). 
iPSCs have shown potential to meet this goal (Li et al., 2016). Direct differentiation of 
iPSC, by the cell-based strategies of establishing direct differentiation protocols for 
every cell type in the body through understanding the signaling pathways that control 
the embryonic development, or by using small molecules, could be used for in vivo 
transplantation, studying diseases in vitro, and discovering new drugs (Li et al., 2016).    
Tissue- and organ-based strategies of regenerative medicine include miniature 
human organoids, decellularization, and, on the other hand, 3D printing and 3D 
bioprinting (Atala & Murphy, 2015). Differentiation protocols of stem cells are used 
in producing miniature human organoids, which are formed through the autonomous 
self-assembly of the cells, resulting in the generation of complex 3D organoids that 
recapitulate the normal tissue or organ development  (Susaimanickam et al., 2017). 
Miniature human organoids are biological tools that can accurately model 
physiological tissue function at the micro-scale, having potential applications in 
disease modeling, drug discovery, and toxicity testing (Atala & Murphy, 2015). These 
organs-on-a-chip are being developed for, e.g., for the lung, liver, heart, skin, and 
kidney (Atala & Murphy, 2015). Furthermore, a combined system of organoids 
representing a body-on-a-chip is in the middle of development, capable of modeling 
the complex interactions between multiple organ systems (Atala & Murphy, 2015), 
and predicting drug efficacy (Kimura, Sakai, & Fujii, 2018). This body-on-a-chip or 
human-on-a-chip is based on the microfluidic devices, containing the functions of 
multiple organs and tissues (Kimura, Sakai, & Fujii, 2018).     
On the other hand, in the decellularization process, all the cellular components and 
primary immunogenic factors, such as cellular proteins and DNA, have been removed 
from an organ with the structural architecture left intact (Moon et al., 2016). This is 
 7 
 
based on the perfusion of an organ with detergents and other chemical agents 
through the vasculature, maintaining the structural integrity of the organ’s 
extracellular matrix (ECM) (Moon et al., 2016), and the inherent vascular network 
(Schmitt et al., 2017). Furthermore, the resulting acellular matrix is repopulated or 
recellularized with organ-specific cells, undergoing some degree of self-organization 
(Moon et al., 2016). This technology has provided a promising approach for the 
production of transplantable organ constructs (Moon et al., 2016), and for tissue 
engineering of solid tissues with an adequate vascularization (Schmitt et al., 2017).  
In the end, producing tissues on demand by 3D printing and 3D bioprinting would 
revolutionize medicine (Dzobo et al., 2018), by creating readily available transplant 
organs and tissues, and, at the same time, eliminating the waiting list for replacement 
parts (Savage, 2016). Printed constructs might be stronger than grafts from the 
donated tissue, fill the tiny crevices that no surgery could address, leading to greater 
overall strength, and avoid the need to cut healthy tissue through printing in the 
shape of the damage (Savage, 2016). In addition, in the future, successive layers of 
biocompatible material laden with cells might be able to deposit straight into a defect 
and the human body could be enhanced with new types of tissues (Savage, 2016). 
The possibilities seem science fiction, but currently, a number of bioengineered 
tissues are in various stages of development, and several clinical trials have begun 
(Sadri-Ardekani & Atala, 2016). Succesful outcomes from these clinical trials will help 
to ensure the future of the regenerative medicine therapies (Sadri-Ardekani & Atala, 
2016).   
1.3 The kidneys    
The functional unit of kidney is nephron which is essential for most renal functions 
(Chuah & Zink, 2017; Lawrence et al., 2018). Human kidney function is underpinned 
by approximately 1 million nephrons, the number of these nephrons varying 
substantially for each person (Chuah & Zink, 2017). The nephron consists of the 
glomerulus and the renal tubule. Filtration of the blood occurs in the glomerulus, 
whereas the glomerular filtrate flows into the renal tubule, starting from the renal 
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proximal tubule (PT) located next to the glomerulus. The loop of Henle connects the 
PT with the distal tubule (DT). DT leads into the collecting duct (CD), and the branched 
CD tree connects the nephrons with the ureter. (Chuah & Zink, 2017).   
The nephrons are in medullas surrounded by the renal interstititum. It consists of 
cells embedded in a complex ECM, whereas the normal interstitium is constructed of 
capillary endothelial cells, dendritic cells, and structural cells which can also be 
referred as fibroblasts. Collagen molecules play a major role in this ECM, mostly 
contributing to the structural integrity. On the other hand, modulating cell 
differentiation, cell growth, and adhesion are also important functions of collagen. In 
the kidney, the most abundant collagens are type I and III collagen. (Alexakis et al., 
2006). The Figure 1 represents more detailly the rough and finer structure of the 
complex kidney.   
Kidneys or, most importantly, proximal tubule cells (PTC) have manifold functions. 
For instance, they control the pH of blood and urine and reabsorb most of the water, 
glucose, peptides and proteins from the glomerular filtrate, are important for 
electrolyte and mineral homeostasis, produce the active form of vitamin D and 
erythropoietin (EPO), clear metabolic wastes, toxicants and xenobiotics by active 
Figure 1. Structure of the kidney. 1a. The rough structure of kidney consists of the shell of the kidney called 
capsule, the tougher region below the capsule called cortex, the small assemblies referred to as medullas, in which 
nephrons are located, and renal arteries and veins which are responsible for the nutrient, oxygen, and carbon 
dioxide transfer of the nephrons and other cells. The structure of the kidney ends with pelvis, in which the urea is 
collected through the CD, and the ureter. 1b. Finer structure of the kidneys inside the medulla is constructed of 
nephron (glomerulus, PT, and DT), and CD. Nephrons are the essential functional units of the kidneys responsible 
for many kidney functions. (Adapted from Chuah & Zink (2017)). 
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transport and secretion of these compounds from the bloodstream into the 
glomerular filtrate, and express a large variety of phase I and phase II enzymes for 
the metabolism of toxicants, organic compounds and drugs, such as cytochrome P450 
enzymes (Chuah & Zink, 2017; Moon et al., 2016).  
However, when the kidney is injured, the damaged renal tissue will undergo several 
disease states and stages, including acute and chronic kidney symptoms (Moon et al., 
2016). Acute renal injury (AKI) is generally defined as a sudden increase in the serum 
creatinine concentration, accompanied by decreased urine output (Moon et al., 
2016). In pathological aspects, AKI shows for example tubular necrosis and apoptosis, 
changes of the filtration barrier, glomerular misfiltration, vasoconstriction and 
tubular obstruction, interstitial swelling, and activation of proteolytic enzymes (Moon 
et al., 2016). When this kidney impairment lasts more than three months, the patient 
has developed a chronic kidney disease (CKD) (Razmaria, 2016). CKD results in 
decreased urine production and kidney failure (Razmaria, 2016). When AKI and CKD 
develop into more severe states, end-stage renal disease (ESRD), the conditions 
affect multiple organs system (Moon et al., 2016).  
1.4 Regeneration of kidneys   
With the ageing population, increasing number of failing organs and organ shortage 
is going to occur (Radenkovic, Soulouk, & Seifalian, 2016). The current treatments are 
not sufficient enough to face this challenge due to the paucity of suitable organ 
donors, the practical hurdles of collecting and storing the organs, the high costs of 
transplantation (Dzobo et al., 2018; Radenkovic, Soulouk, & Seifalian, 2016), and the 
immune responses caused by transplants and mortality of lifelong 
immunosuppression of dialysis (Radenkovic, Soulouk, & Seifalian, 2016). Even if 
dialysis is capable of replacing renal filtration function by removing certain toxins 
from the blood, it is unable to restore for example the production of EPO and 
activation of vitamin D (Moon et al., 2016). This decreases the quality of life and long-
term survival (Moon et al., 2016). Current treatment of AKI and CKD is limited to this 
life-long dialysis (Moon et al., 2016).   
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Better options for the treatment of for example AKI and CKD is cell-based approach 
in which the damaged regions are regenerated with functional renal specific cells 
(Moon et al., 2016). Some of the cell-based therapies using transplantation of 
autologous, primary renal cells and stem cells are now clinically applicable, whereas 
the pre-clicinal and clinical applications of the fully functional, engineered renal 
constructs stay challenging (Moon et al., 2016). On the other hand, the only definitive 
treatment for ESRD is kidney transplantation (Moon et al., 2016). It is dramatically 
limited by an inadequate supply of transplantable grafts and by the heavy toxicity 
related to lifelong immunosuppression due to the inadequate etiology and 
pathophysiology (Peloso et al., 2016).  
However, tissue engineering and regenerative medicine are developing multiple 
approaches and strategies to enhance the treatments for AKI, CKD, and ESRD (Moon 
et al., 2016; Peloso et al., 2016). These strategies for the treatments include 
aforementioned cell therapies and tissue engineered 3D renal constructs for AKI and 
CKD, and whole kidney engineering for ESRD (Moon et al., 2016). For example, several 
types of mesenchymal stem cells (MSCs) have shown promising results in kidney 
repair, and skeletal muscle-derived stem/progenitor cells (MDSPCs) have been 
considered as a potential strategy for the treatment of AKI (Pavyde, Usas, & 
Maciulaitis, 2016). Decellularization of organs has shown promise in whole kidney 
engineering, but many challenges should be addressed before the clinical 
applications (Moon et al., 2016). Bioreactors, mimicking the in vivo environment, 
delivering nutrients within perfused medium, and monitoring physiological 
parameters of tissue development, could be used to develop a reproducible 
recellularization strategy for the requirements of clinical applications (Lin et al., 
2016).  
Other strategies are developmental biology in the form of miniature human 
organoids, 3D bioprinting, and a kidney-on-a-chip technology (Peloso et al., 2016). 
Kidney organoids have been studied lately (Takasato et al., 2015; Takasato & Little, 
2016), many kidney-on-a-chip researches have been conducted based on, e.g., renal 
tubule epithelial cells, and 3D bioprinting can already be used in teaching models of 
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renal tumor localization or kidney surgigal models for planning and training purposes 
(Lin et al., 2016). Ultimately, four-dimensional (4D) printing is the latest, emerging 
strategy of regenerative medicine in kidney bioengineering, producing products 
capable of adjusting themselves according to their surroundings (Lin et al., 2016). In 
the Figure 2, the different regenerative solutions for the kidney bioengineering can 
be seen in more detail.  
Figure 2. Five regenerative medicine technologies applied for the treatment of kidney diseases. As it can be seen, all the 
technologies have weaknesses that hinder their potential. Mostly the weaknesses consider the ability of the constructs to 
mimick the ones in the human body, e.g., filtration, re-cellularization, microarchitecture and oxygenation, or technical 
development. However, re-cellularised scaffolds or cell-on-scaffold technology has the biggest potential for the fast 
translation. (Peloso et al., 2016). 
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2. Three-dimensional bioprinting   
2.1. The basics   
Three-dimensional (3D) bioprinting, also known as 3D bioprinting, biofabrication, 
additive fabrication, rapid prototyping, and solid-free form technology, was first 
developed in the early 1990s (Francis & Bulletin, 2015; Sultan & Mathew, 2018). It 
was derived from 3D printing which was described in the 1980s by Charles Hull from 
the University of Colorado, under the name stereolithograpgy (Dai et al., 2019; Gao 
& Cui, 2016; Radenkovic, Soulouk, & Seifalian, 2016; Sultan & Mathew, 2018). In 
general, 3D bioprinting is a multidisciplinary technology that combines the 
knowledge from different discplines, including energy, engineering, biology, 
biotechnology, material, information, as well as medicine, and mainly focuses on the 
life sciences and medicine (Zhang et al., 2018; Dai et al., 2019). The major difference 
of 3D bioprinting compared to 3D printing are the utilized materials, which are mainly 
biomaterials, cells, and growth factors (Zhang et al., 2018). The current progress of 
3D bioprinting is still at an early stage, and more research and understanding 
considering this field is needed before the industrial applications (Gao & Cui, 2016).   
However, as a technology, 3D bioprinting has showed many advantages (Leppiniemi 
et al., 2017; Piras et al., 2017; Savage, 2016). When compared to the more 
conventional technologies, 3D bioprinters can build complex objects that were not 
possible earlier, e.g., internal contours where no tool could reach (Piras et al., 2017; 
Savage, 2016). In addition, 3D bioprinting offers lighter structures, better product 
performance, and lower production costs due to the missing of moulds and other 
manufacturing tools, high reproducibility, fine control of the process, and up-
scalability (Leppiniemi et al., 2017; Piras et al., 2017). It also allows the distribution of 
different cell types, biochemical factors, proteins, and drugs at the desired locations, 
i.e., biomaterials and ECM components (Francis & Bulletin, 2015; Piras et al., 2017), 
which has typically been one of the major problems associated with populating 
scaffolds with cells (Dzobo et al., 2018). The revolutionary advantages of 3D 
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bioprinting are personalized products and mass customization (Leppiniemi et al., 
2017; Sultan & Mathew, 2018).   
Due to these many advantages, 3D bioprinting has gained a lot of attention in the 
biomedical applications in which it has a more and more important role (Zhang et al., 
2018). 3D bioprinting has been used in customized models to allow preoperative 
surgigal planning of high risk operations, medical education, and guiding the 
construction of medical implants (Zhang et al., 2018; Radenkovic, Soulouk, & 
Seifalian, 2016). It has also been used in human permanent implants, biomimetic 
scaffolds, drug testing models, controlled drug releasing, surgigal cutting and drill 
guides, and tissue engineering and wound-healing applications (Zhang et al., 2018; 
Leppiniemi et al., 2017). Considering the scaffolds and implants, numerous 
applications of 3D bioprinting have been reported in literature from bone and 
cartilage scaffolds, skin and prevascularised tissues fabrication, cardiac constructs to 
neuronal tissue and muscle–tendon units (Piras et al., 2017; Radenkovic, Soulouk, & 
Seifalian, 2016;  Vijayavenkataraman, et al., 2018).  To mention a few, a bioresorbable 
tracheal splint was fabricated using 3D bioprinting and succesfully implanted in a 
child (Radenkovic, Soulouk, & Seifalian, 2016).  
2.2. Technologies   
The main technologies suitable for 3D bioprinting of biomaterials in regenerative 
medicine include inkjet (DBB), microextrusion (MBB), and laser-assisted bioprinting 
(LBB) (Dzobo et al., 2018; Li et al., 2016; Mandrycky et al., 2016; Murphy & Atala, 
2014). Recently, also stereolithograpgy (SLA) bioprinting, traditionally used in the 
basic 3D printing, has been modified to fabricate cell-laden scaffolds (Lee et al., 2017; 
Neiman et al., 2015; Owen et al., 2016; Wang et al., 2015; Zhu et al., 2018). All these 
technologies have their distinct advantages, disadvantages, and limitations (Lou et 
al., 2014; Mandrycky et al., 2016). Thus, different features of these technologies 
should be considered in light of the most important factors in 3D bioprinting, such as 
surface resolution, cell viability, and the properties of the biomaterials used for the 
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3D bioprinting (Murphy & Atala, 2014). No single 3D bioprinting technology is able to 
produce all scales and complexities of the tissues (Mandrycky et al., 2016).  
Inkjet bioprinters use thermal or acoustic forces to eject drops of liquid onto a 
substrate in 3D bioprinting (Dzobo et al., 2018; Murphy & Atala, 2014). Thermal inkjet 
bioprinters function by electrically heating the printhead to produce pulses of 
pressure that force droplets from the nozzle, whereas acoustic inkjet bioprinters use 
an acoustic radiation force associated with an ultrasound field to eject liquid droplets 
from an air-liquid interface (Dzobo et al., 2018; Murphy & Atala, 2014). 
Microextrusion bioprinting is a modification of DBB, in which uninterrupted 
cylindrical lines rather than a liquid bioink droplets are printed (Mandrycky et al., 
2016). MBB uses an air-force pump, a mechanical screw, or a plunger (Dzobo et al., 
2018; Mandrycky et al., 2016; Tappa & Jammalamadaka, 2018). In the laser-assisted 
bioprinting, a laser pulse vaporizes a portion of the donor layer, creating a high-
pressure bubble at the interface of the bioink layer, which in turn moves the 
suspended bioink (Mandrycky et al., 2016; Murphy & Atala, 2014). In the end, the 
falling bioink droplet is collected on the receiving substrate and cross-linked 
(Mandrycky et al., 2016; Murphy & Atala, 2014). On the other hand, the SLA 
bioprinting polymerizes light-sensitive polymer materials layer-by-layer by the light, 
additively building up 3D structures, using digital micromirror arrays which control 
the light intensity of the printing area (Lim et al., 2018; Wang et al., 2015; Wang et 
al., 2018). The schematic representation of the current main bioprinting technologies 
can be seen in the Figure 3 below.   
Figure 3. The different 3D bioprinting technologies. DBB is based on thermal or acoustic operation and MBB 
on the air-force pump, mechanical screw, or plunger, whereas LBB is based on the laser pulse. (Mandrycky et 
al., 2016; Murphy & Atala, 2014). A. Inkjet bioprinting. B. Microextrusion bioprinting. C. Laser-assisted 
bioprinting. (Murphy & Atala, 2014). 
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Each current 3D bioprinting technology requires bioinks with the specific rheological 
properties and has a different effect on the cell viability. Microextrusion bioprinting 
supports a wide range of viscosities, ranging between 30 mPa·s and 6*107 mPa·s 
(Axpe & Oyen, 2016;  Mandrycky et al., 2016; Murphy & Atala, 2014; Ozbolat et al., 
2017). Nevertheless, the cell density within the bioinks can be very high, and the 
shear stress during the extrusion process decreases the cell viability, resulting in the 
cell viability of 80% - 90% (Axpe & Oyen, 2016). Thus, MBB has the lowest cell viability. 
In inkjet-based bioprinting, the viscosity level is supported between 3.5 mPa·s and 12 
mPa·s, which depends on the bioink concentration (Mandrycky et al., 2016; Ozbolat 
et al., 2017). In general, bioinks in DBB are less viscous (<10 mPa·s), have lower cell 
densities (<16*106 cells/mL) compared to microextrusion, and offers cell viabilities 
of around 90% (Axpe & Oyen, 2016). On the other hand, the viscosity for laser-
assisted bioprinting ranges between 1 and 300 mPa·s (Axpe & Oyen, 2016;  
Mandrycky et al., 2016; Murphy & Atala, 2014; Ozbolat, 2017). In addition, the 
medium cell densities in LBB are around 108 cells/mL and the cell viability is the 
highest from the methods, (>95%) (Axpe & Oyen, 2016). The overall differences 
between these three major 3D bioprinting technologies are listed in short in the Table 
1 below.   
Table 1. The differences between the major 3D bioprinting technologies. (Adapted from Mandrycky et al. (2016) 
and Murphy & Atala (2014)).   
Parameters Inkjet (DBB) Microextrusion (MBB) Laser assisted (LBB) 
Supported viscosities 3.5 - 12 mPa·s 39 mPa·s to >6*107 mPa·s 1 - 300 mPa·s 
Print speed Fast (1 - 10.000 
droplets per second) 
Slow (10 - 50 µm/s) From medium to fast 
(200 - 1.600 mm/s) 
Resolution High Moderate High 
Quality of vertical structure Poor Good Fair 
Gelation methods Chemical and photo-
cross-linking 
Chemical and photo-cross-
linking, shear thinning, and 
temperature 
Chemical and photo-
cross-linking 
Cell densities Low, <106 cells/ml High (cell spheroids) Medium, 108 cells/ml 
Cell viability >85% 40-80% >95% 
Printer cost Low Moderate High 
 
Based on the earlier descriptions and the Table 1, each of the 3D bioprinting 
technologies has their advantages and limitations. With MBB, highly viscous bioinks, 
such as cellular spheroids, complex polymers, and almost all types of hydrogel pre-
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polymer solutions with high cell densities for tissue formation, can be printed (Bishop 
et al., 2017; Dzobo et al., 2018; Mandrycky et al., 2016). This is also the case with the 
laser-assisted bioprinting, in which the nozzle-free technology does not cause 
mechanical stress on the cells or clogging of the nozzle (Mandrycky et al., 2016; 
Murphy & Atala, 2014). This results in, e.g., the possibility to use a broader range of 
the biomaterials in 3D bioprinting (Mandrycky et al., 2016). The bioinks with the 
lowest viscosity and the narrowest viscosity range can be used in the case of the inkjet 
bioprinting. This is due to the excessive force required to eject drops with solutions 
of higher viscosities and the requirement of the biomaterials to be in a liquid form 
(Murphy & Atala, 2014). To maintain biological materials in the liquid form, also the 
number of cells within the bioink is lowered (Dzobo et al., 2018). Furthermore, 
clogging can occur in the DBB (Mandrycky et al., 2016), which is increased with the 
high cell concentrations (Dzobo et al., 2018).    
In addition to the viscosity range, the easiness of operation and handling of the cells 
is another difference between these technologies. According to the Table 1, DBB and 
LBB have a higher printing speed and resolution when compared to the MBB, 
enhancing the operation easiness, but microextrusion printing have more cross-
linking methods. When it comes to the cells, MBB and LBB can be used to achieve cell 
densities similar to those found under physiological conditions (Dzobo et al., 2018), 
with minimum effect on cellular viability and function in the case of LBB due to the 
lack of directly applied force to the cells (Dzobo et al., 2018; Wang et al., 2015).  In 
the case of MBB, the high extrusion pressures result in the distortion of cellular 
structure and loss of cellular viability (Bishop et al., 2017), which can also be seen 
from the Table 1. Nevertheless, the disadvantages of the LBB are the possible side 
effects of the laser exposure on the cells and an inaccurate targeting and positioning 
of these cells (Mandrycky et al., 2016), together with the metallic residues in the 
bioprinted materials (Dzobo et al., 2018). On the other hand, the advantage of the 
inkjet bioprinting is the possibility to produce droplets with uniform cellular density 
and the potential to introduce concentration gradients of cells, materials, or growth 
factors by altering the drop densities or sizes (Murphy & Atala, 2014).  
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The cost and availability have their own effect on the use of the 3D bioprinting 
technologies. Inkjet and microextrusion bioprinting are both low cost and common 
technologies, from which the DBB is the first bioprinting technology and a modified 
version of the 2D ink-printing (Mandrycky et al., 2016; Murphy & Atala, 2014). Thus, 
the availability of 2D printers in the research laboratories make it possible to widely 
use this 3D bioprinting technology (Murphy & Atala, 2014). On the other hand, laser-
assisted bioprinters have a high cost, a complex control of the laser printing system, 
and they are rather rare (Mandrycky et al., 2016; Wang et al., 2015).      
Interestingly, the high resolution down to 200 µm, high speed, and cell viability higher 
than 90%, due to the nozzle-free technology, makes the stereolithograhy-based 
bioprinting a competitive technology when compared to the other presented 
technologies, especially in comparison to DBB and MBB (Wang et al., 2015; Wang et 
al., 2018). Most importantly, SLA allows high spatial resolution, which helps to better 
mimick the complex architecture and microenvironment of the tissues and organs 
(Lim et al., 2018). Further, SLA considerably reduces the printing time when 
compared to the other bioprinting technologies (Wang et al., 2015).  
However, SLA is not yet fully customized for 3D bioprinting (Wang et al., 2015), which 
can be harmful for the bioprinted cells, and the UV light and near-UV blue light (405 
nm) mostly utilized in this technology damage the cell DNA, are toxic to mammalian 
cells, and disrupt the cellular processes (Wang et al., 2015; Wang et al., 2018). Visible-
light-sensitive photoinitiators and polymerization are thus recommended (Wang et 
al., 2018). Therefore, many obstacles must be overcome for the SLA bioprinting to 
become fully compatible in 3D bioprinting of the cells and biological materials. As 
mentioned before, a single bioprinter cannot alone to make all the complexities of 
the tissues, and the proper 3D bioprinting technology needs to be selected according 
to many factors, such as the cell viability and the properties of the biomaterials.     
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2.3. Components and operation   
Commercial 3D bioprinters are available, e.g. from Cellink® and regenHU. In general, 
as also explained in the Subchapter 2.2, the available printers include cheaper inkjet 
bioprinters with a small droplet size and viscosity, more expensive but slower 
microextrusion bioprinters with continuous release of material, and finally the most 
expensive laser-assisted bioprinters with the highest viscosity, resolution, and cell 
viability (Axpe & Oyen, 2016; Radenkovic, Soulouk, & Seifalian, 2016). The most 
existing commercial bioprinters, such as the Bioplotter and NovoGen 3D Bioprinting 
platform, are based on the extrusion technology (Murphy & Atala, 2014).  
However, lately the term customizable which means manufacturing of the consumer-
specific products, have became more and more important also in the case of the 3D 
bioprinters (Mandrycky et al., 2016; Murphy & Atala, 2014). These tailored and thus 
consumer-specific 3D bioprinters are meant to decrease the possible high prices 
associated to 3D bioprinters, especially with the laser-assisted ones, to better meet 
the needs of the consumers and to enhance the 3D bioprinting performance 
(Campbell et al., 2015; Fitzsimmons et al., 2018).   
Due to this trend, researchers worldwide have started to develop different types of 
3D bioprinters with slight variations and performance (Campbell et al., 2015; 
Fitzsimmons et al., 2018). In addition, Mandrycky et al. (2016) reported a few 
investigations and their attempts to enhance inkjet- and laser-assisted bioprinters. 
Thus, the amount and placement of the components of the 3D bioprinters seem to 
vary depending on the manufacturer, the 3D bioprinting technology, and the target 
application. In this thesis, BioX 3D bioprinter from Cellink® was utilized. The 
technology used in this biopinter is microextrusion with the pneumatic print heads. 
The components and the structure of the BioX 3D bioprinter and an example of 
ongoing bioprinting process can be seen in the Figure 4.     
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In the case of 3D bioprinting as the manufacturing process, the operation of the 3D 
bioprinter is divided into six different steps. These steps are; imaging of the desired 
tissue or organ, designing of the 3D model, material selection for the bioink, cell type 
selection, bioprinting process itself, and the end-use selection for the 3D bioprinted 
hydrogel (Murphy & Atala, 2014). The different steps are presented in a nutshell in 
the Figure 5 below, followed by the detail descriptions.  
 
Figure 5. The steps of 3D bioprinting process. (Murphy & Atala, 2014).  
Computed tomography (CT) and magnetic resonance imaging (MRI) are noninvasive 
imaging models which are used to provide information on 3D structure and function 
Figure 4. The different components of the BioX 3D Bioprinter from Cellink® and the operation of the 3D bioprinter. 
3D bioprinting can be utilized in manufacturing structures in the micrometer scale with high precision and 
orientation through layer-by-layer deposition (Zhang et al., 2018). 1. Clean chamber (tm) unit. 2a. UV sterilization 
LED 1. 2b. UV sterilization LED 2. 3a. Printhead mount 1. 3b. Printhead mount 2. 3c. Printhead mount 3. 4a. Photo 
curing module mount 1. 4b. Photo curing module mount 2. 5. Printbead. 6. 7’’ touch screen. 7. USB port. 8. 
Protective door. (Adapted from BIO X 3D Bioprinter User Manual (2017) and Campbell et al. (2015)).  
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at the cellular, tissue, organ, and organism level (Dzobo et al., 2018; Murphy & Atala, 
2014). CT images are based on the slices of the tissue or organ architecture, revealing 
the true volume of these tissues or organs, whereas MRI functions by the nuclear 
magnetic resonance, showing a powerful contrast resolution in the tissue or organ 
images (Dzobo et al., 2018). Further, computer-aided design and computer-aided 
manufacturing (CAD-CAM) tools and software with the mathematical modelling 
techniques are used to convert this obtained structural and functional data into 3D 
models (Dzobo et al., 2018), which is also called the design process. This design 
process in 3D bioprinting is based on three central design strategies, which are 
biomimicry, autonomous self-assembly, and mini-tissue building blocks (Atala & 
Murphy, 2015; Murphy & Atala, 2014; Li et al., 2018).  
In more detail, biomimicry involves the manufacture of the identical reproductions 
of the cellular and extracellular components of a tissue or an organ, whereas 
autonomous self-assembly utilizes the early cellular components, embryonic or stem 
cells, in producing their own ECM components, appropriate cell signaling, 
autonomous organization, and patterning to yield a certain biological 
microarchitecture and function of a tissue or an organ. On the other hand, the 
concept of mini-tissues is a combination of the earlier methods and is divided into 
two main strategies. First, self-assembling cell spheres are assembled into a macro-
tissue using biologically inspired design and organization. Second, accurate, high-
resolution reproductions of a tissue unit are designed and allowed to self-assemble 
into a functional macro-tissue. In the end, all these strategies are required to print a 
complex 3D biological structure with multiple functional, structural, and mechanical 
components and properties. (Murphy & Atala, 2014).   
In the end, these created 3D models, utilizing the design strategies described earlier, 
are  exported to the 3D bioprinter in the form of, e.g., .stl files (Li et al., 2018). .Stl 
(strereolithograpgy) and .vrml (virtual reality modeling language) file formats are the 
most used ones (Tappa & Jammalamadaka, 2018), however, .obj file format have also 
lately been gaining popularity due to its ability to add colors and texture information 
on the manufactured 3D models. Nowadays, a variety of different CAD or CAD-CAM 
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softwares exists, from free to paid ones. SolidWorks, AutoCAD, and ZBrush are some 
examples of popular CAD software used commercially in industries, whereas the 
freeware for making 3D models include Blender, FreeCAD, Meshmixer, OpenSCAD, 
and SketchUp (Tappa & Jammalamadaka, 2018). After all these steps, the 3D 
bioprinting process itself is started. This process is explained in more detail in the 
Chapter 9.  
2.4. Materials in 3D bioprinting  
The basic raw material of 3D bioprinting is called bioink (Ozbolat et al., 2017). In 
general, bioinks can be cell-suspensions, cell-hydrogel mixtures, or biocompatible 
materials, from which the cell-hydrogel mixtures and biocompatible materials are the 
latest approaches (Li et al., 2018). Therefore, in 3D bioprinting, these bioinks are 
composed of various biopolymers with properties matching the sufficient operation 
of 3D bioprinter, together with the cell support and growth (Axpe & Oyen, 2016). 
Important features of an ideal bioink material include, e.g., bioprintability, high 
mechanical integrity and stability, insolubility in cell culture medium, biodegradability 
at an appropriate rate, non-toxicity and non-immunogenicity, and the ability to 
promote cell adhesion (Ozbolat et al., 2017).  
Bioink materials should also be easily manufactured and processed, affordable, and 
commercially available, and bioprinted constructs composed of bioinks are expected 
to keep their designed shape, structural strength and integrity, easily engraft with the 
host, and degrade over time in vivo (Ozbolat et al., 2017). Currently, there are 
commercially available bioinks that offer reproducible results, such as Gel4Cell®, 
CellInk®, BioInk®, OsteoInk®, Bio127®, BioGel® (Tappa & Jammalamadaka, 2018), and 
GrowDex©. The main requirements for the bioinks and the bioink requirements in 
different bioprinting technologies are listed in the Figure 6 below.    
 22 
 
 
 
  
 
In general, two major types of bioink materials have been utilized in the bioprinting 
processes of 3D tissue and organ constructs. These are scaffold-based and scaffold-
free materials. Scaffold-based materials are the most common bioinks, and they 
include hydrogels, microcarriers, and decellularized matrix components, whereas 
scaffold-free bioink materials are basically cell aggregates. In scaffold-based bioinks, 
cells are loaded in exogenous materials, such as hydrogels, which is followed by 
bioprinting into 3D constructs. In scaffold-free bioinks, engineered neo-tissues that 
contain cells are deposited in specific patterns, which results in fusion and maturation 
of the cells into more complex tissues. (Ozbolat et al., 2017).  
Recently, hydrogels have been extensively used as bioinks for the production of 3D 
bio-constructs (Park et al., 2017). Hydrogels are gel like, often cross-linked, capable 
of absorbing and retaining large quantities of water, biocompatible, highly permeable 
to oxygen, nutrients and other water-soluble compounds, show low cytotoxicity, and 
have tissue-like stiffness (Axpe & Oyen, 2016; Ozbolat et al., 2017; Markstedt et al., 
2015; Park et al., 2017). Thus, hydrogels have structural and physicochemical 
similarities to ECM (Ozbolat et al., 2017; Park et al., 2017). The water content of the 
hydrogels is the most essential factor because biocompatibility of hydrogels and their 
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structural similarity to ECM is influenced by their inherent hydration levels (Ozbolat 
et al., 2017). In fact, hydrogels are mostly water by weight, but exhibit no flow in the 
steady-state due to the 3D cross-linked polymer network within the fluid, which gives 
them unique properties comparable to those of human tissues (Axpe & Oyen, 2016; 
Ozbolat et al., 2017).   
Hydrogel must be viscous enough to retain its shape after printing and must have 
cross-linking abilities allowing for it to retain the 3D structure after bioprinting 
(Markstedt et al., 2015). Cross-linking can be achieved by, e.g., temperature change, 
UV photopolymerization, and ionic cross-linking (Markstedt et al., 2015). Therefore, 
in general, hydrogel cross-linking methods consist of non-covalent and covalent 
cross-linking methods, latter synthetized by chemical reactions or enzymatically 
catalyzed reactions (Ozbolat et al., 2017). Ionic cross-linking minimizes the risk of 
chemical contamination or chemical-induced toxicity, by involving noncovalent 
interactions formed when the ions of opposite charges electrostatically attract each 
other (Ozbolat et al., 2017). On the other hand, chemically cross-linked hydrogel is 
based on covalent bonding between polymer chains. Chemical cross-linking can 
provide better mechanical stability, but the use of a cross-linker could result in 
cytotoxicity. Photo-cross-linking is an example of the used chemical cross-linking 
methods (Ozbolat et al., 2017). Other interactions that may influence on the hydrogel 
formation include host-guest interactions, hydrogen bonds, van der Waals forces, 
hydrophobic interactions, and interlacking of the chains (Nascimento et al., 2018).  
To mention a few bioink compositions, composite materials of alginate and CNF have 
shown promising results for 3D bioprinting and tissue engineering applications 
(Aarstad et al., 2017). This is based especially on the shear thinning properties of CNF 
combined with the viscous alginate that forms ionically cross-linked hydrogels with 
divalent cations at physiological conditions (Aarstad et al., 2017). Particularly, soft 
tissue cartilage-formation through 3D bioprinting, utilizing alginate-CNF composite 
hydrogels, have been a popular topic among researchers in the past few years 
(Nguyen et al., 2017; Markstedt et al., 2015; Sultan et al., 2017). This hydrogel 
composite maintains the pluripotency of the iPSCs, and is a suitable material for the 
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proliferation and growth of the cells (Nguyen et al., 2017). Alginate contributes with 
elastic properties and increases mechanical resistance at large deformations, 
whereas CNFs reduce the syneresis, the volume reduction upon gel formation, of the 
alginate gels and contributes to the increased resistance against compression at small 
deformations. This can be seen by an increase in Young’s modulus or the rigidity of 
the gel. These results, for their part, make the combination of CNF and alginate a 
multifunctional and promising candidate for various bioink formulations.  
Recently, lignin has been introduced into printing inks as a performance enhancer, to 
take an example, lignin-coated CNC in combination with methacrylate resin (MA) 
(Feng et al., 2017). The addition of lignin-coated CNCs increased the mechanical 
strength and thermal stability of the printed matrix (Feng et al., 2017). Elsewhere, 
increased lignin concentrations in PLA-lignin nanofibres alleviated undesirable 
inhibition of cell proliferation and provided antioxidant activity (Kai et al., 2016). 
Other possible uses of lignin could be incorporation into hydrogels to tune the 
hydrophilicity of the resulting matrix, and the development of lignin-based 
nanoparticles as nanocarriers for drug delivery. Therefore, in general, scalable lignin-
based products obtained by applying 3D printing approaches would be promising in 
the future (Xu et al., 2018).   
2.5. Tissue and organ regeneration   
Tissue and organ diseases and loss are anticipated to exacerbate due to the aging 
population, making tissue and organ shortage a severe challenge worldwide (Francis 
& Bulletin, 2015).  Already today, patients on various organ recipient waiting lists pass 
away before suitable donor organs become available (Francis & Bulletin, 2015). Thus, 
one of the most promising properties of tissue engineering and regenerative 
medicine is the possibility to make organ scaffolds that may reduce or eliminate the 
need for donor organs (Francis & Bulletin, 2015). One possible tool for this could be 
3D printing and 3D bioprinting (Zhang et al., 2018; Francis & Bulletin, 2015), from 
which 3D bioprinting has been considered as one of the most advanced technologies 
in the field of tissue engineering and regenerative medicine (Sultan et al., 2017).  
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3D bioprinting has multiple good physical properties which enable its use in tissue 
engineering. 3D bioprinted scaffolds could mimic the characteristics and anatomical 
geometry of the desired tissues and organs, abolish the problems with manual cell 
seeding, and have a reproducible and standardized pore size, facilitating cell 
proliferation and aggregation. In addition, by combining biological and synthetic 
bioresorbable materials, 3D printed scaffolds could have enhanced load-bearing 
properties than original human tissues. (Radenkovic, Soulouk, & Seifalian, 2016).   
Furthermore, 3D bioprinting technologies can be easily automated and integrated 
with imaging techniques to produce anatomically-correct structures, e.g. scaffolds, 
with customized size and shape for an individual patient (Axpe & Oyen, 2016; 
Leppiniemi et al., 2017; Lee & Dai, 2017). The uses of these 3D functional scaffolds 
and living tissues include degradation and remodeling studies, study of the cell-
biomaterial interactions at the nanoscale level, drug testing or toxicological studies, 
and real transplantation in animals (Axpe & Oyen, 2016; Lee & Dai, 2017). In the 
Figure 7 below, these different uses of 3D bioprinted tissues are listed in more detail.   
Figure 7. Different uses of 3D bioprinted structures in regenerative medicine. A. As it can be seen, the extracted 
cells, for example stem cells, can be used, e.g., for in vitro disease study, drug discovery, and even transplantation. 
The extracted stem cells enable the production of patient-specific tissues and organs. B. 3D bioprinting can be 
used in the multiple stages. It can be used to bioprint structures in the molecule size, certain cell types, and even 
tissues and organs. However, the size limits of bioprintable structures are dependent on the 3D bioprinter type, 
and the regeneration of the most complex organs still require more research. (Adapted from Li et al. (2016) and 
Mandrycky et al. (2016)).  
Thus, the studies of 3D bioprinting considering especially, e.g., toxicity screening, 
material possibilities for cell culturing and fabrication of tissues, is currently a popular 
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research area. Zhang et al. (2016) fabricated an endothelialized myocardium on-a-
chip for toxicity screening, using the novel hybrid strategy based on 3D bioprinting, 
whereas  Markstedt et al. (2015) printed human chondrocytes in the multiple shapes, 
e.g., in the shape of an human ear, with a bioink consisting of CNF and alginate. 
Elsewhere, Kesti et al. (2015) printed nose structures, using the bioink of gellan and 
alginate mixed with human micronized BioCartilage or hydroxyapatite (HA) particles. 
On their behalf, Keriquel et al. (2017) 3D bioprinted mesenchymal stromal cells with 
collagen and nano-HA for the bone regeneration. The Figure 8 below summarizes a 
few tissues and organ constructs, which have been produced through 3D bioprinting 
technology.     
 
Figure 8. Different tissue and organ constructs manufactured with 3D bioprinting. A. Schematics of a nephron 
and the different steps in the fabrication of 3D convoluted, perfusable proximal tubules, in which a fugitive ink was 
first printed on a gelatin-fibrinogen ECM (Homan et al., 2016). B. Gartilaginous nose grafts with the size of the 
adult nose (Kesti et al., 2015). C. Bioprinted liver tissue organoids mimicking the hepatic lobules of native liver 
tissues with tissue-like cellular density and tight intercellular junctions. Human primary hepatocytes, endothelial 
cells, and hepatic stellate cells were used. (Zhang et al., 2017). D. 3D bioprinted heart with an internal structure 
(Zhang et al., 2017). E. NHA-collagen and D1 cells bioprinted in a ring or disk geometry in the bone regeneration 
(Keriquel et al., 2017). F. 3D bioprinted ear-shaped cartilage (Markstedt et al., 2015). Ear-shaped cartilage could 
be the first bio-printed tissue in the clinical use (Savage, 2016). G. Endothelialized myocardium on-a-chip (Zhang 
et al., 2016).  
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As it can be seen also from the Figure 8, 3D bioprinting’s ultimate medical application 
would be in a 3D bioprinting of human organs (Radenkovic, Soulouk, & Seifalian, 
2016). However, it is a long way to fabricate this kind of a live organ (Zhang et al., 
2018). Nevertheless, there already are a few studies attempting to 3D bioprint 
smaller parts of the solid organs, their general shapes without inner cell constructs, 
or 3D constructs containing only few interacting cell types of the specific organ 
(Figliuzzi et al., 2017; Zhang et al., 2017; Zhong et al., 2016; Wu et al., 2018) These 
studies are focused especially on the heart and liver (Zhang et al., 2017; Zhong et al., 
2016; Wu et al., 2018). An extremely small number of researches considering kidneys 
can be found, which makes it an important research area for the future. These few 
researches available are studying, e.g., the decellularization of the kidneys for kidney 
regeneration, self-assembling of the tissue spheroids to fabricate a kidney mini-
tissue, or the utilization of the silicon droplets as physical analogues of tissue 
spheroids in making the kidney arterial vascular tree (Homan et al., 2016; Figliuzzi et 
al., 2017; Vijayavenkataraman et al., 2017; Unbekandt & Davies, 2010).  
Furthermore, a 3D bioprinting company Organovo has published many studies during 
2015 - 2017 describing attempts to bioprint kidney structures that mimick as much 
as possible the structure of the native human kidney. Organovo has printed, e.g., 3D 
consoluted renal proximal tubules on perfusable chips, microscopic veins that make 
up a kidney, mini kidneys, and the base of a human kidney for drug-testing (Jackson, 
2016; Jackson, 2017; Jackson, 2018). In general, multiple challenges exist before the 
whole and functional kidneys can be bioprinted. These challenges include the 
architectural complexity of kidney, limited availability of primary cells, the formation 
of nephrons equivalent to that of the native kidney, and the formulation of a bioink 
that will resemble the complex renal structure and functionality. Bioprinting of tissue 
spheroids is one potential approach to overcome these challenges. 
(Vijayavenkataraman et al., 2017).   
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3. Biopolymers for 3D bioprinting     
3.1. Biopolymers in general    
As we can see from the Figure 9, many materials have been used for the fabrication 
of bioinks in 3D bioprinting, from synthetic materials to the bio-based ones. Synthetic 
materials include for example poly(ethylene glycol) (PEG) and Pluronic, together with 
polycaprolactone (PCL) and poly(l-lactide-co-glycolide) (PLGA) (Gopinathan & Noh, 
2018; Ullah et al., 2018). On the other hand, biomaterials are composed of 
polysaccharides, such as starch, cellulose, chitin, chitosan, and alginate and 
polysaccharides synthetized from bacterial, fungal, and animal proteins, such as 
collagen, gelatin, silk, and fibroin (Gunathilake et al., 2017; Kapoor & Kundu, 2016). 
The advantages of biomaterials are their biocompatibility, biodegradability, non-
toxicity, similarity to ECM of the human body, and thus, good acceptance by 
biological systems, whereas synthetic materials are excellent when it comes to the 
mechanical properties and customization (Gunathilake et al., 2017; Mogoşanu & 
Grumezescu, 2014; Naseri-nosar & Maria, 2018). Thus, biomaterials are often 
reinforced with the synthetic ones (Chinga-Carrasco, 2018). The Figure 9 below 
reveals the biomaterial distributions of the few common synthetic and bio-based 
materials in the current bioinks.   
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Figure 9. Synthetic polymer and biopolymer distributions in the used bioinks  
(Adapted from Ullah et al. (2018)).   
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According to the Figure 9 and recently published articles, the most used biomaterials 
in 3D bioprinting and regenerative medicine are alginate, hyaluronic acid (HA), 
collagen, and gelatin (Ullah et al., 2018). CNF and CNCs have become more popular 
in the recent years due to their good properties in combination with other 
biomaterials, such as biocompatibility, high strength, high surface area, tuneable 
surface chemistry, non-cytotoxicity against a series of cell lines, and the lack of 
disease transmittance due to the plant-based origin (Dai et al., 2019; Xu et al., 2018). 
On the other hand, only rare biomaterial options include lignin (Larrañeta et al., 
2018), silk fibroin (Park et al., 2013), and gellan gum (Yu, Kaonis, & Chen, 2017).  
Among these biomaterials, alginate is the most common material in the current 
bioinks (Axpe & Oyen, 2016). It is Isolated from the cell walls of brown algae, having 
a structure of a linear polysaccharide, composed of (1–4)-linked β-D-mannuronic and 
α-L-guluronic acids (Axpe & Oyen, 2016; Markstedt et al., 2015). As a material, 
alginate supports cell growth, exhibits high biocompatibility, is non-immunogenic, 
low-cost, and forms hydrogels under mild conditions (Axpe & Oyen, 2016). The 
applications of alginate include cell encapsulation and cell cultures of, e.g. organoids 
and embryos (Ozbolat et al., 2017).   
When taking an example from the recent materials, CNF is a plant-derived 
biomaterial, composed of aligned b-D-(1/4)-glucopyranose polysaccharide chains 
and extracted by mechanical, e.g., grinding, and chemical treatments, e.g., TEMPO-
mediated oxidation (Lou et al., 2014; Piras et al., 2017; Sultan et al., 2017). CNF is 
non-cytotoxic, flexible, has highly entangled networks, a high viscosity, shear-
thinning properties, good properties already at concentrations lower than 1 wt%, and 
hydrogel forming properties (Piras et al., 2017; Xu et al., 2018). As a material, CNF 
can be used as rheological modifiers, potential carriers for functional components, 
and components in hydrogels (Leppiniemi et al., 2017; Sultan et al., 2017). CNF could 
also be an appropriate option for modeling of 3D tumors and therefore, an important 
material in the cancer research (Chinga-Carrasco, 2018). In the Table 2, a few studies 
considering CNF-based applications have been summarized. 
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Table 2. The latest and interesting material, bioink, and 3D bioprinting studies considering CNF and MCF.   
 
On the other hand, another recently popular material, CNCs, can be obtained from 
cotton and wood, which yield a narrow distribution of highly crystalline nanorod, and 
tunicin, bacteria, and algae, which generate crystals with larger polydispersity and 
dimensions, through the removal of amorphous sections of purified cellulose utilizing 
acid hydrolysis (Klemm et al., 2011; Piras et al., 2017; Sultan et al., 2017). The 
obtained CNCs are highly crystalline, rod-like particles with the width of 5 - 70 nm 
and length between 100 nm and several micrometers (Klemm et al., 2011). CNCs are 
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anisotropic particles with limited flexibility, high aspect ratio, and outstanding 
mechanical properties (Klemm et al., 2011; Siqueira et al., 2017). They have been 
used as a reinforcement in alginate-based composites and as one of the components 
in 3D printable inks (Leppiniemi et al., 2017).  
As a new material source, utilization of industrial lignin is constantly becoming more 
important (Lievonen et al., 2016; Lintinen et al., 2018; Ashok et al., 2018). Lignin is 
the complex, hydrophobic biopolymer built of phenylpropanoid units, and it is a main 
by-product from pulping and biorefineries (Lintinen et al., 2018; Munk et al., 2015). 
Lignin owns many useful features for the purposes of regenerative medicine (Xu et 
al., 2018). It is abundant, low-cost, and considered biocompatible, biodegradable, 
and CO2 neutral material (Figueiredo et al., 2018; Liu et al., 2019), with good 
rheological charasteristics, good viscoelastic properties, and film-forming capacity 
(Figueiredo et al., 2018). It can enhance the cell adhesion in scaffolds, possess high 
stability, possibly abating the scaffold degradation rates, and has antimicrobial, 
antifungal, and antioxidant properties (Figueiredo et al., 2018; Quraishi et al., 2015). 
Primarily, lignin adds strength and rigidity to the cell walls, allows the transport of 
water and solutes, provides physical barrier against invasion by phytopathogens, and 
prevents the degradation of the structural polysaccharides in the cell wall (Figueiredo 
et al., 2018; Lievonen et al., 2016).  
The major disadvantages of this material are the possible cytotoxicity for some cell 
types at high dozes due to the phenolic nature of lignin (Quraishi et al., 2015), the 
imprecisely defined structure depending on the origin of lignin (Lievonen et al., 2016), 
together with the infusibility and insolubility of lignin in common solvents (Lievonen 
et al., 201; Liu et al., 2019). This insolubility has been one factor in hindering the 
exploration of lignin and lignocellulosic biomass as bioinks for 3D bioprinting (Liu et 
al., 2019). Other application areas of lignin include drug encapsulation and release 
(Dai et al., 2018; Figueiredo et al., 2017; Witzler et al., 2018), which has been a 
popular research area in the recent years, scaffolds (Farhat et al., 2017; Witzler et al., 
2018), bioactive coatings for implants (Erakovic et al., 2014; Witzler et al., 2018), and 
utilization of the antibacterial properties of lignin (Witzler et al., 2018).      
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Recently, nano- and microscale lignin particles have arisen as promising alternatives 
to regular lignin (Nypelö, Carrillo, & Rojas, 2015; Sipponen et al., 2017), due to their 
enhanced properties. Most importantly, the preparation of CLPs through the 
aqueous lignin nanoparticle dispersions overcomes the problems of poor solubility 
and miscibility of regular lignin (Lievonen et al., 2016). CLPs can be produced from 
lignin, e.g., using a straightforward and green production process introduced by 
Lievonen et al. (2016), resulting in CLPs with the desired spherical particle 
morphology and colloidal stability (Lievonen et al., 2016). In this process, regular 
lignin is first dissolved into tetrahydrofuran (THF), which is followed by the filtration 
of the solution, and dialysis using periodically replaced deionized water (Lievonen et 
al., 2016). CLPs are formed during the dialysis in minimum 24 hours (Lievonen et al., 
2016).  
Many process variations considering the CLP production naturally exist due to the 
urge to establish processes suitable also for the low-cost, efficient, green, and large-
scale industrial use. Lignin nanoparticles have been synthesized by 
thermomechanical treatments, acid and solvent-antisolvent precipitation, 
emulsification and microemulsification (Nypelö, Carrillo, & Rojas, 2015), as well as 
CO2 saturation, continuous solvent exchange, dialysis, and sonication (Richter et al., 
2016).  Nevertheless, most of the published processes are energy intensive, consume 
considerable number of reagents, involve the use of hazardous chemicals, or produce 
too diluted products not suitable for the large-scale production (Ashok et al., 2018). 
Other drawbacks include the lack of particle integrity and control of size and size 
distribution (Nypelö, Carrillo, & Rojas, 2015). The latest and most promising up-scaled 
CLP production methods include the processes of Leskinen et al. (2017) and Lintinen 
et al. (2018). The process of Leskinen et al. (2017) includes the steps of recovery of 
the utilized solvent by evaporation, drying of formed CLPs into solid form, and re-
dispersing them into an aqueous dispersion (Leskinen et al., 2017), whereas Lintinen 
et al. (2018) introduce a closed cycle process for the large-scale production of CLPs 
at low cost. Further, Ashok et al. (2018) have compiled a techno-economic 
assessment of a large-scale continuous flow process for producing commercially 
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significant amounts of dry colloidal lignin, based on the previously introduced process 
developed by Lintinen et al. (2018).  
In general, CLPs are interesting components for many biomaterial applications due to 
their smooth surface structure and stability in physiological conditions (Mattinen et 
al., 2018). CLPs have been commercially used in, i.e., additives, binders, dispersants, 
and surfactants (Lievonen et al., 2016). Furthermore, they hold a great potential in 
bio-based adhesives, crop additives, stabilizers, antimicrobial materials, and wound 
healing applications (Lievonen et al., 2016), together with nanocomposites (Lievonen 
et al., 2016; Ashok et al., 2018), controlled drug delivery (Lievonen et al., 2016; Ashok 
et al., 2018), and functional surface coatings (Ashok et al., 2018). Particularly colloidal 
cationic lignin particles have been reported to be excellent in stabilizing pickering 
emulsions (Sipponen et al., 2017). Above all, a new promising application area of CLPs 
is a component in 3D printable bioinks and hydrogels, as described in more detail in 
this Master’s thesis. Nevertheless, other researches considering the utilization of 
CLPs as a component in 3D printable bioinks are not yet available.     
In the case of the rarely used biomaterials, silk fibroin is a natural fibrous protein 
originating from silk, spun by silkoworms or insects (Gopinathan & Noh, 2018; Kapoor 
& Kundu, 2016; Park et al., 2013). The pure fibroin component can be obtained by 
removing sericin using various degumming conditions (Kapoor & Kundu, 2016; Park 
et al., 2013). The properties of silk fibroin are biocompatibility, oxygen and water 
permeability, biodegradability, minimal inflammatory response, and an ability to 
form hydrogels directly through self-assembly of protein chains into physically cross-
linked β-sheet crystals with the rate of sol-gel transition, dependent on protein 
concentration, temperature, metal ions, and pH (Park et al., 2013; Ming et al., 2016). 
The applications of silk fibroin are films, sponges, mats, gels, scaffolds, and tubes 
(Kapoor & Kundu, 2016). For example, Zheng et al. (2018) prepared free-standing silk-
PEG bioink with excellent printability, high resolution, and supported mesenchymal 
stem cell viability for a longer period. In the Table 3, other common biomaterials used 
in 3D bioprinting together with their characteristics have been listed.  
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Table 3. Characteristics of a few common and rare biomaterials used in bioinks for 3D bioprinting. 
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3.2. Challenges in 3D bioprinting  
3D bioprinting is a relatively new research area and it faces challenges in terms of 
specific technical, material, cellular, financial, and clinical aspects of the process 
(Francis & Bulletin, 2015; Radenkovic, Soulouk & Seifalian, 2016; Sadri-Ardekani & 
Atala, 2016; Sultan et al., 2017; Lee & Dai, 2017). Compared with traditional 3D 
printing, 3D bioprinting involves complexities, including the choice of materials, cell 
types, growth and differentiation factors, technical challenges related to the 
sensitivities of living cells and the construction of tissues, biocompatibility 
requirements with living cells and ECM, and the need to mimic the cell-matrix 
architectures and mechanical properties of the native tissues. Thus, it is essential to 
develop new technologies and biomaterials for 3D bioprinting, understand the 
complex cell-matrix interactions behind certain properties, and establish proper 
vascular perfusion in bioprinted tissues (Lee & Dai, 2017).  
The central technical challenges considering 3D bioprinting include adaptation of 
technologies designed to print molten plastics and metals in 3D printing to the 
bioprinting of living biological materials and reproduction of the complex micro-
architecture of ECM components and multiple cell types in sufficient resolution to 
obtain biological functions (Murphy & Atala, 2014). To take an example, 3D 
bioprinting of organs is challenging due to their complex native structures, which can 
consist of dozen or more cell types, and a need for a realistic vascular system that 
carry nutrients to the cells (Zhang et al., 2016; Savage, 2016). Furthermore, cells that 
are not within 200 µm from a nutrient source, die (Savage, 2016). Other common 
technical and material related challenges in 3D bioprinting are collapsing, shape 
fidelity, shrinking and swelling of the hydrogels, clogging of the nozzle-based 
fabrication methods, and, on the other hand, homogeneity, miscibility, print pattern 
and charge of the materials of the bioinks, the type of added bioink components, and 
the viscosity increase of the bioinks due to the CNF already at low concentrations 
(Derakhshanfar et al., 2018; Leppiniemi et al., 2017; Markstedt et al., 2015; Markstedt 
et al., 2017; Sultan et al., 2017).  
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Collapsing is typical for bio-based hydrogels, which is due to a low dry-matter content 
and low viscosity of the bioinks (Leppiniemi et al., 2017; Markstedt et al., 2015). On 
the other hand, shape fidelity is related to the viscoelastic properties of the bioinks. 
This means that the bioink should flow through the nozzle and retain its shape after 
printing and curing (Leppiniemi et al., 2017). However, it is a very challenging task to 
develop viscoelastic bioinks that can be readily extruded, and at the same time form 
self-supporting features after exiting the nozzle (Siqueira et al., 2017). Furthermore, 
swelling of the hydrogels need to be monitored and controlled to prevent blocking of 
the hydrogel pores which are important for the adequate transfer of the nutrients to 
the cells. The usual swelling of the hydrogels is approximately 10%. In addition, 
bioprinted hydrogels need to be kept in non-moving environment after fabrication, 
otherwise the position of cells inside the hydrogel can change. 
When considering the homogeneity, miscibility and types of used materials for the 
bioinks, the successful printability requires homogeneous bioinks to enable a 
consistent flow without clogging while printing, which can be achieved using, e.g., 
speed mixer before 3D bioprinting to remove air bubbles (Markstedt et al., 2015; 
Markstedt et al., 2017). Miscibility also affects homogeneity of the bioinks, which can 
be enhanced with proper interactions between the bioink components, for example 
by proper cross-linking (Markstedt et al., 2017). On the other hand, print pattern may 
have a significant effect on the shape fidelity and stability, and strong charge can 
cause ionic repulsion which can later lead to a phase separation (Leppiniemi et al., 
2017). In addition, adding components to ink can dilute the ink, possibly changing the 
rheological properties and influencing on cross-linking and printability (Markstedt et 
al., 2017).  
The cellular challenges, in turn, include the cell-damaging steps of production 
processes, e.g., exposure to chemical cross-linkers during storaging, mechanical 
stress, toxic solvents, high temperatures and strong UV laser during 3D bioprinting 
process, limitations of each 3D bioprinting technologies in terms of resolution, speed 
and biocompatibility, challenges in analyzing cell behaviors in situ in hydrogel 
systems, limited supply of nutrients in the printed 3D constructs, and poor availability 
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of suitable biomaterials (Axpe & Oyen, 2016; Liu et al., 2017; Short et al., 2017; Lee 
& Dai, 2017). In more detail, current choice of materials for soft tissue bioprinting in 
comparison to hard materials without cell embedment is very limited and already 
existing materials cannot fully mimick the composition of native ECM. This increases 
the need to find and adapt new materials to improve the cell survival rate. (Liu et al., 
2017; Lee & Dai, 2017).  
On the other hand, the cost associated to 3D bioprinting as well as the  design induced 
limitations also form their own challenges (Radenkovic, Soulouk, & Seifalian, 2016). 
3D bioprinting of live cells using biological materials is significantly more expensive 
compared to the conventional 3D printing (Radenkovic, Soulouk, & Seifalian, 2016). 
However, these high values are reasonable if the scaffods can be used to cut the costs 
of organ transplantations (Radenkovic, Soulouk, & Seifalian, 2016). On the other 
hand, the poor transformation of the complex CAD design into machine instructions 
can result in the differences between the 3D model and the bioprinted object (Tappa 
& Jammalamadaka, 2018).  
When considering clinical challenges in contrast to rapid development of 3D 
bioprinting technologies, the translation of 3D printing into clinical therapies has 
been very slow. Only few studies have utilized 3D printed scaffolds in preclinical 
models, not to mention in patients or in-patient clinical trials. However, the potential 
of 3D bioprinting to reduce the organ shortage, acts as the main driving force in 
translation of 3D bioprinting technologies and scaffolds into clinical medicine. 
(Francis & Bulletin, 2015).  
In general, translational medicine studies have taken place in bone, cartilage, teeth, 
and skin regeneration (Francis & Bulletin, 2015). However, current preclinical and 
clinical studies have mainly focused on simple and hard tissues, such as bone and 
tooth regeneration and implantation, whereas soft tissue regeneration using 3D 
bioprinting simultaneously with living cells and its translation into medicine is still at 
very early stage (Lee & Dai, 2017). Only a few preclinical studies have been conducted 
for the regeneration of more complex, internal organs, e.g., lungs, kidneys, liver, and 
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heart (Francis & Bulletin, 2015). This is due to the many problems associated with the 
safe and sufficient clinical use of the 3D printed scaffolds, including the technical 
difficulties of scaffold production in mimicking complex structures, development and 
behavior of cells in terms of rate of vascularization, innervation and diffusion of 
metabolies, cell survival, safety of biomaterials, financial costs, abundant cell sources, 
and ethical aspects (Francis & Bulletin, 2015; Radenkovic, Soulouk, & Seifalian, 2016; 
Sadri-Ardekani & Atala, 2016; Lee & Dai, 2017). In addition, finding the optimal 
scaffold manufacturer protocol is a difficult task which also hinders the translation 
process of 3D bioprinting into applications of clinical medicine (Radenkovic, Soulouk, 
& Seifalian, 2016).  
3.3. Solutions and the future   
In the recent years, many exciting research attempts have been made considering 3D 
bioprinting technology and materials, from which personalized 3D bioprinting is 
becoming more and more popular in the future (Radenkovic, Soulouk, & Seifalian, 
2016), and several companies are working with the applications of 3D bioprinting for 
the needs of regenerative medicine (Derakhshanfar et al., 2018). To take and 
example, Organov has recently introduced a bioprinted human liver for the 
commercial use (Derakhshanfar et al., 2018). In gerenal, 3D bioprinting industry is 
growing and is expected to grow even more in near future. According to 
Derakhshanfar et al. (2018), 3D printing market size is predicted to reach $10.8 billion 
in 2021 from $2.2 billion in 2012.  
Nevertheless, as described in the previous Subchapter 3.2, there are many problems 
associated with 3D bioprinting. To overcome these problems, hydrogels can be 
printed in combination with other biomaterials, or using a combination of different 
hydrogel fabrication and cross-linking methods (Axpe & Oyen, 2016; Markstedt et al., 
2015; Markstedt et al., 2017; Ullah et al., 2018). As an example, inkjet bioprinting 
technology can be used for fast printing in centimeter- and millimeter scale of certain 
tissue constructs, and microextrusion for the constructs in the microscale (Lee & Dai, 
2017). This technology, also called multimaterial bioprinting, provides the ability to 
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adjust factors, such as concentration of growth factors, cell adhesion and degradation 
rate in the different regions of the bioprinted object, and enables to load different 
types of cells in different zones, allowing for closely mimicking of natural cellular 
diversity and acitivity (Derakhshanfar et al., 2018). Mixing of different technologies 
and materials, and the future progresses in it, can enable the fabrication of new 
tissues and organs with challenging structures and adequate cell viability and 
function.   
The development of new printers and printing technologies will have an important 
role in this attempt. With a novel Kenzan bioprinter, cell spheroids are able to be 
bioprinted in a pre-designed manner to mimick the shape of the blood vessels (Itoh 
et al., 2015), whereas digital micro-mirror device-based projection printing (DMD-PP) 
could be used to fabricate user-designed vascular channels with the channel widths 
of 25-120 µm in a highly short time (Datta et al., 2017). On the other hand, 
bioplotting, in which air pressure is used to extrude the bioink, is appropriate to 
extrude low viscosity liquids, such as polymer melts, biopolymers, and nanocellulose 
gels, and to produce complex shapes that would be unfeasible through traditional 
manufacturing technologies (Rees et al., 2014). Elsewhere, gradual cross-linking of 
sodium alginate with calcium ions before, during, and after printing increases the 
printability of the alginate material and mechanical rigidity, layer adhesion capability, 
and overall structure stability of the 3D bioprinted hydrogels (Tabriz et al., 2015). A 
living body could also serve as a bioreactor for in vivo growth of scaffolds seeded with 
viable cells after 3D bioprinting (Ullah et al., 2018).    
On the other hand, the tissue repair and drug delivery performance could be 
improved by using novel biorobots. There is an increasing demand for small, 
biocompatible robotic devices that can perform tissue repair, cargo transport, drug 
delivery, and to help to understand the locomotive mechanism of small-scale micro-
organisms (Nagarajan et al., 2018). Williams et al. (2014) prepared a biorobot based 
on cardiomyocyte and polymethylsiloxane (PDMS) to model spermatozoa, whereas 
Park et al. (2017) developed a biorobot based on cardiac cells and PDMS body and 
modeled on an electric sting ray. In general, 3D bioprinting in the fabrication of 
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biorobots would decrease the manufacturing costs and enable an easy design and 
finetuning of these devices with improved motility for various biomedical 
applications (Nagarajan et al., 2018).     
In relation to the new findings considering bioinks, the use of high concentration 
bioinks of CNF are expected in the near future, helping to develop materials with new 
mechanical, structural, and functional performance (Sultan et al., 2017), whereas the 
preparation of dynamic, switchable, and oxygen producing hydrogels could provide 
the base for establishing strategies to control cell microenvironment (Ullah et al., 
2018), and possibly enhance cell survival. Another extremely interesting research 
area, which may have a big potential in the future, is the fabrication of patient-
specific bioinks based on the platelet-rich plasma (PRP) as a source of the patient-
specific growth and biological factors with enhanced stem cell migration and 
vascularization (Faramarzi et al. 2018).  
One increasing future approach in the case of 3D bioprintable inks may also be lignin. 
Lignin could act as a filler or structure stabilizer in the 3D bioprinted hydrogels and, 
on the other hand, behave as an active compound in delivering substances to the 
cells (Dai et al., 2019; Xu et al., 2018). This feature might be extremely good in the 
accurate delivery of growth factors for cell differentiation, fabrication of many 
proliferated cell lines inside the hydrogel, and in creating the suitable and best 
possible environment for tissue or organ regeneration. In the end, in the Table 4, 
some more recent and promising researches considering 3D bioprinting and bioinks, 
to overcome the current problems, has been collected.    
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Table 4. A short summary of the recent, interesting 3D bioprinting and bioink studies using different 
biomaterials, biofabrication technologies, and cell sources. 
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EXPERIMENTAL 
4. Objectives of the work   
The object of this Master’s thesis is to test the hypothesis, according to which the 
addition of CLPs prevents hydrogel shrinking upon drying. This is done by preparing 
CLP-CNF-alginate bioinks with varying CLP concentrations and studying their 
rheology, printability, compression, and in the end, their structural stability in 
different storage conditions. The ultimate objective is to make lignin in the form of 
CLPs a multifunctional and promising material option for 3D bioprinting in 
regenerative medicine.   
5. Materials   
5.1. Nanofibrillated cellulose (CNF)  
Bleached birch wood pulp fibres were utilized for the TEMPO-oxidized CNF and 
unmodified CNF. 1.5 liters of TEMPO-oxidized CNF was prepared according to the 
instructions in the Subchapters 5.1.1 - 5.1.4, whereas 1 liter of 2.5% unmodified CNF 
was provided by Aalto University, after prepared according to the articles of 
Pääkkönen et al. (2016) and Rojo et al. (2015). The preparation of 2.5% unmodified 
CNF consisted of washing the birch wood pulp fibres to sodium form prior to the 
disintegration in the fluidizer, dilution of the alkaline treated pulp, disintegration of 
the pulp suspension with M-110P fluidizer using six passes, and storing the resulted 
2.5% unmodified CNF in the fridge at 4 °C.      
5.1.1.  Alkaline treatment of cellulose pulp 
Alkaline treatment of cellulose was used as a pre-treatment before TEMPO-oxidation 
to increase the anionic charge due to the carboxylic acid groups, -COOH, that form 
during the oxidation. First, cellulose fibres were ripped by hand into smaller pieces of 
about 1 mm of length. This was followed by weighing, and the weight of the cellulose 
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pieces obtained was 90.04 g. Next, the cellulose pieces were poured into 1 liter of 1 
M sodium hydroxide, NaOH, and stirred to homogeneity.  
After 15 minutes, the alkaline cellulose pulp was washed with tap water and finally 
with deionized water, until the value of pH reached 9.9. The total consumption of 
water was approximately 20 liters. Next, the washed cellulose was added in small 
amounts into a mixing machine (Kenwood electronics) and mixed until the texture 
was the desired one. After the mixing, the cellulose was pressed and added into a 
plastic bag. The final weight of the moist sodium cellulose was 309.58 g.  
Dry weight analysis was conducted for the cellulose. After cellulose had been kept in 
the oven overnight, the sample was let to cool in the desiccator for 15 minutes before 
the final measurement. The dry matter content of washed cellulose was 34%, and the 
amount of moist cellulose required for the TEMPO-oxidation was 205.79 g. The 
calculations for the dry weight analysis and the amount of moist cellulose can be 
found in the Appendix 1. The different steps of alkaline pre-treatment of cellulose are 
also shortly listed in the Figure 10.   
5.1.2. TEMPO-oxidation of cellulose  
Preparations for TEMPO-mediated oxidation, shortly TEMPO-oxidation, of cellulose 
consisted of the preparation of TEMPO-catalyst and titration of hypochlorite, CIO-. 
TEMPO-catalyst was used in the TEMPO-oxidation of cellulose and titration to 
Figure 10. Different steps of alkaline treatment of cellulose. A. Ripped cellulose fibre mats. B. Cellulose mass after 
15 minutes of immersion in 1 M NaOH. C. Washed cellulose mass. D. Finished sodium cellulose fibres ready for 
TEMPO-oxidation. 
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estimate the used thiosulfate, S2O32-, consumption in TEMPO-oxidation. In the 
preparation of TEMPO-catalyst, 0.572 g of TEMPO-catalyst was measured together 
with 41.574 mol of distilled water, after which the solution was let to react in a 
container over the weekend. After the reaction, 4 ml of hypochlorite was added, 
followed by shaking of the container by hand and pipetting of sulfuric acid, H2SO4, (1 
M) to adjust the pH around 7.  
In the titration of hypochlorite, 10 ml of potassium chloride, Kl, (10 %) and 20 ml of 
sulfuric acid (1 M) was added into the beaker, followed by the addition of 0.5 ml of 
hypochlorite. The solution was titrated using 19.58 ml of sodium thiosulfate, Na2S2O3, 
(0.101 mol/l), until the color of the solution started to lighten up. Starch was added 
in the middle of the titration to achieve a blue color and titration was conducted, 
until the equivalent point was reached. The equivalent point was reached when the 
color of the solution became transparent. The obtained thiosulfate consumption was 
19.755 ml, the average of two separate titrations.  
After the preparations, TEMPO-oxidation of cellulose was started. In the beginning, 
205.803 g of washed cellulose, that contributed to the dry weight of 50 g of dry 
cellulose, was poured to the Büchiglasuster bmd 300 reactor apparatus together with 
1.5 liters of distilled water. This was followed by the addition of 825 g of distilled 
water and the previously prepared TEMPO-catalyst. To start the reaction and adjust 
the pH to the desired level, 125 ml of hypochlorite was measured and added into the 
reactor small amounts at a time. The reaction started immediately when pH started 
to decrease due to the addition of hypochlorite. After this, pH was measured 
continously. When the reaction speed slowed down, and the hypochlorite 
concentration decreased in the reactor apparatus, small amounts of 4% NaOH (1 M) 
was added to maintain pH 8 - 9. The overall consumption of 1 M NaOH during the 
reaction was 114.3 g, until the reaction was stopped after 4 ½ hours.    
In the end of TEMPO-oxidation, the reacted cellulose was washed with deionized 
water for about four times. Alltogether, 320.1 g of moist TEMPO-oxidized cellulose 
was obtained at dry weight of 13% and 82.11% yield. The calculations of the dry 
 45 
 
weight analysis and yield of the TEMPO-oxidized cellulose can be observed in the 
Appendix 1. The steps of TEMPO-oxidation of cellulose are also summarized in the 
Figure 11 below.  
5.1.3. Acid treatment of TEMPO-oxidized cellulose  
The acid treatment of TEMPO-oxidized cellulose was performed to enhance the 
separation of the fibres in fluidization using the repulsion of the metals in their ion 
form, such as Na+. Metals in their ion form also enhanced the non-packing of the 
cellulose fibres. In the beginning of the treatment, 32.0 g of TEMPO-oxidized cellulose 
was weighed into the beaker and diluted to 1.5 kg with deionized water. A little 
amount of 1 M HCL was added into the beaker, and the pH of TEMPO-oxidized 
cellulose was adjusted to 1.8, so that the protonization of the cellulose occurred. 
Protonization made the structure of cellulose more fluid-like.  
Next, the obtained TEMPO-oxidized cellulose solution was let to mix and react using 
the magnetic stirrer for about 50 minutes, which was followed by the conductivity 
measurements. The obtained conductivity of TEMPO-oxidized cellulose was 0.8 
Figure 11. The steps of TEMPO-oxidation of cellulose. A1. TEMPO-oxidized cellulose was added into the 
Büchiglasuster bmd 300 reactor. A2. The TEMPO-catalyst was added into the reactor together with distilled water. 
B. 4% NaOH (1 M) was pipetted to keep the pH in the range of 8 - 9. The reaction lasted for 4 ½ hours. C. In the 
end of the reaction, the TEMPO-cellulose was poured to the Viira bag for washing. D. The obtained, weighed, and 
mashed TEMPO-cellulose ready for the dry weight analysis.   
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microsiemens/cm, and the limit for the conductivity 5. After the conductivity 
measurement, TEMPO-oxidized cellulose was washed for five times with the beaker 
and once straight from the tap with Viira bag, ripped by hand into smaller pieces to 
enhance the dry matter of the cellulose, and moved into the plastic bag. The plastic 
bag was gently mashed to enhance the dry matter content of the cellulose, followed 
by the dry weight analysis. The dry weight of the moist cellulose was 25.92% and yield 
90.90%. The calculations of the dry weight analysis and yield of the acid-treated 
TEMPO-oxidized cellulose can be seen in the Appendix 1.  
In the next step, conductometric titration was conducted using Methrom’s 751 GPD 
Titrino to obtain the amount of carboxylic acid groups, -COOH, in the TEMPO-oxidized 
cellulose backbone. In the beginning of this measurement, 1.126 g of the acid 
treatred TEMPO-cellulose, 1.5 liters of Milli-Q water from which air and acidic CO2 
had been removed in ½ hours, 1 ml of NaCl (0.5 M), and 0.5 ml of HCl (1 M) were 
weighed into the beaker. TEMPO-oxidized cellulose was let to disperse for 
approximately 10 - 15 minutes to make the conductometric titration work better, 
followed by the titration. During the titration, the speed was lowered to 300 rpm 
soon after the starting, and the titration was let to proceed for a litte bit over 20 
hours.  
Titration curves were analyzed using Origin 2018b software. The amount of first 
results was 1.21 mmol COOH/g pulp. After two hours, the second results were 
obtained, and the measurement was ended. The carboxylic acid group content was 
1.26 mmol COOH/g pulp. The average of these two measurements was 
approximately 1.23 mmol COOH/g pulp. The overall consumption of NaOH was 0.368 
mmol at the velocity of 0.1 ml/min.   
5.1.4. Fluidization of TEMPO-oxidized cellulose  
The fluidization, to obtain the CNF fibres, was started with the dilution of TEMPO-
oxidized cellulose. 233.7 g of TEMPO-cellulose was weighed and diluted with 
deionized water until the overall weigh of 1119.9 g ≈ 1.2 kg was reached. Next, pH 
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was adjusted to 9 with pipetting 1 M NaOH drop by drop. This dilution and adjusting 
of pH of TEMPO-cellulose was followed by fluidization. The utilized fluidizer was 
Microfluidics M-110P produced by Microfluidics™, USA. The fluidization was started 
with the initial preparations. During the fluidization of over 45 minutes at the 
pressure of 2000 bars, 2% TEMPO-cellulose was constantly added into the fluidizer, 
when the tube got empty, at the same time CNF being produced as a long tube, and 
a bag of ice was kept on the machine during the process to keep the fluidizer cool. 
The obtained TEMPO-CNF was stored in the fridge at 4 °C.  The steps of the 
fluidization are also shortly summarized in the Figure 12 below.  
 
 
 
 
 
 
5.2. Colloidal lignin nanoparticles (CLPs)  
UPM BioPivaTM lignin from softwood kraft pulping was utilized for the preparation of 
the CLPs. The CLP preparation included five main steps. These were 1) dissolution of 
Figure 12. The steps of the fluidization process. A. TEMPO-oxidized cellulose was diluted to the desired weight 
and concentration by adding deionized water. B. The deionized water was used for cleaning the fluidizer, followed 
by the addition of 2.5% and 2% TEMPO-cellulose into the tube located on the left in the Microfluidics M-110P 
fluidizer. C. TEMPO-cellulose was prosessed through the tubes of the fluidizer in the pressure of 2000 bars. CNF 
fibres were produced simultaneously when TEMPO-cellulose was added. D. 2.0% CNF fibres were obtained. The 
fluidizer was again cleaned by the distilled water. E. A closer look of the produced CNF fibres. Fibres were long, 
gel-like tubes which maintained their structure.   
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lignin, 2) self-assembly/nanoprecipitation of CLPs in water, 3) dialysis to remove the 
organic solvent, 4) concentration by rotary evaporation, and 5) freeze-drying of the 
CLP dispersion. These different steps are shortly presented in the Figure 13 below, 
followed by the detail descriptions.              
The preparation of the colloidal lignin particles (CLPs) was started by weighing 2.288 
g of 65.6 wt% lignin, 37.49 g of distilled water and 112.5 ml of acetone into the 
beaker, after which the lignin was dissolved in a capped beaker using a magnetic 
stirrer at the temperature of 22 °C for three hours. After three hours of stirring, the 
solution was filtered using a Whatman© glass microfibre filters GF/F to remove the 
undissolved particles. This was followed by the quick pouring of the solution to the 
450.16 g of water in two seconds using a magnetic stirrer, after which the resulted 
dispersion was let to stir for 15 minutes. The faster the pouring, the bigger the particle 
size of CLPs.   
CLPs were purified by dialysis against deionized water using SpectraPos dialysis 
membrane with 6 - 8 kD as the pore size. The weight of the CLP dispersion after the 
Figure 13. The different steps of the preparation of colloidal lignin particles (CLPs). A. The process was started with 
mxing the different reagents, including water, acetone, and lignin as the form of powder, in a specific order to 
obtain CLPs with the defined particle size. The particle size of the CLPs was dependent on the pouring speed of the 
lignin-water-acetone solution into water. B. The next step was the dialysis of the generated CLP-water-acetone 
dispersion in the filter paper sausages. During the dialysis, the excess acetone was removed from the sausages into 
the surrounding water. This step also included the particle size determination of the CLPs. C. The following step was 
the rotary evaporation and concentration of the CLP dispersion. In this step, the certain amount of water was 
evaporated from the dispersion until the overall weight of approximately 150 g was reached.  D. The preparation 
ended to the freeze-drying process of the CLPs into the solid form for the bioink preparation.         
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dialysis was 712.68 g, and the dry weight of the CLPs after the dry weight analysis 
0.211%. The calculations for the dry weight analysis of the CLP dispersion can be seen 
in the Appendix 1. This second step also included the particle size determination of 
the CLPs through the dynamic light scattering (DLS) measurements. Before the DLS 
measurements, the CLP dispersion was filtered using Whatman© glass microfibre 
filter GF/F with the pore diameter of 0.7 µm to remove the bigger particles and 
therefore, to prevent later aggregation. In the DLS measurements, instrument of 
Malvern and the software of Zetasizer produced by Malvern Panalytical Ltd, UK, was 
used, and two measurements were conducted.   
According to the measurements, the mean particle diameter, Z-average, of the CLPs 
was 103.0 nm, whereas the width of the particle size distribution, polydispersity index 
(PDI), was 0.108. According to Shaw (2015), the obtained range is the mid-range value 
of PDI. These results indicate that the prepared CLPs are not monodisperse but 
slightly polydisperse with an average distribution of the particle sizes (Shaw, 2015). 
The results from the particle size determination can be observed in more detail in the 
Table 5 below.   
Table 5. Particle sizes of the CLPs obtained from the DSL measurements.   
1:2, water to lignin solution   
 Z-average PDI 
Mean 103.0 0.108 
Standard deviation 1.609 0.003 
 
The fourth step was the rotary evaporation and concentration of the CLP dispersion 
at the temperature of 50 °C. Rotavapor R-210 apparatus from Büchi was used to 
evaporate 712.68 g of 0.211 wt% CLPs to a final weight of approximately 150 g. The 
concentrated CLP dispersion was freeze-dried using the Labconco Freezone Plus 4.5 
Litre Benchtop Freeze Dryer. The weight of the generated CLPs was 3.051 g and the 
yield 75.0%. The calculations considering the yield of the CLPs can be seen in the 
Appendix 1.    
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5.3. Excipients  
The excipients used for the bioink preparation, 3D bioprinting, and storage methods 
included the alginate solution and gel, cross-linking solution based on 0.09 M calcium 
chloride, CaCl2, together with salt-water solution. To begin, 0.5% alginate solution 
was prepared by weighing 1.25 g of alginate powder, product #180947-500G, from 
Sigma Aldrich into the beaker and adding distilled water, until the overall weight of 
50 ml was reached. 10% alginate gel was prepared by weighing 1 g of alginate powder 
from Sigma Aldrich and 9 g of distilled water into the beaker, by stirring with spatula 
and later overnight by the magnetic stirrer.  
0.09 mol/l of cross-linking solution based on CaCl2 was prepared by weighing 13.232 
g of CaCl2 into the flask of 1000 ml, which was followed by the addition of distilled 
water, until the overall weight of 1 liter was achieved. Furthermore, an aqueous 
buffer solution was prepared by weighing 0.200 g of CaCl2 (Merck, purity 98%), 0.093 
g of magnesium sulfate (anhydrous), MgSO4 (VWR Life Science, purity ≤ 99.5%), 3.700 
g of sodium bicarbonate, NaHCO3 (VWR BDH Chemicals, purity 100%), 6.400 g of 
sodium chloride, NaCl (VWR BDH Chemicals, purity 99.9%), 0.100 g of sodium 
phosphate monobasic (anhydrous), NaH2PO4 (Fluka, purity < 99.0%), and 0.400 g of 
potassium chloride, KCl (Merck, purity 99.5%), into a 1000 ml flask, followed by the 
addition of distilled water, until the overall weight of 1 liter was reached. The 
composition of the salt-water solution was adapted from the Dulbecco’s Modified 
Eagle’s Medium (DME) from Sigma Aldrich and inspired by the articles of Laurén et 
al. (2017) and McKee & Komarova (2017).     
5.4.  Bioinks  
The materials prepared in the previous Subchapters 5.1 - 5.2 were utilized in 
preparing the bioinks, according to the recipe of the CNF-alginate bioink adapted 
from Markstedt et al. (2015). In this bioink preparation process, alginate powder was 
first dissolved in water, followed by the dissolution of the CLPs with the B. Braun’s 
(HT) shaker for overnight, and the addition of either CNF or T-CNF. This 
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homogenization of sodium alginate and CLPs in water also diluted the initial CNF 
concentration from 2.5 wt% to 2 wt%, and the initial T-CNF concentration from 2.0 
wt% to 1.9 wt%.  
After the addition of the different components, the bioinks were centrifuged to 
remove all the air bubbles, making them more suitable for 3D bioprinting. The 
Centrifuge 5804 R from Eppendorf and the fixed-angle rotor FA-45-6-30 with 
Eppendorf Quicklock© lid was used with the centrifugation radius of 12.3 cm and the 
relative centrifugal force (RCF) of 220. The evaluation of the proper centrifuging 
parameters is more thoroughly described in the Chapter 7. The appearance of the 
different bioinks and their preparation methods are presented in more detail in the 
Figure 14, and the compositions of the bioinks used in the Table 6 below.        
 
Figure 14. The appearance and preparation steps of the various bioinks. It is evident that the colour of the bioinks 
turn into more brownish with the increased CLP concentrations. A. CNF-alginate bioink. B. 1% CLP-CNF-alginate 
bioink. C. 5% CLP-CNF-alginate bioink. D. 10% CLP-CNF-alginate bioink. E. 25% CLP-CNF-alginate bioink. F. Steps 
for the bioink preparation in short in the form of a scheme. 
Table 6. The compositions and preparation methods of the different bioinks. 
Bioink composition Initial 
CNF 
(wt%) 
CNF: 
bioink 
(wt%) 
CNF: 
bioink 
(g) 
Alginate: 
bioink 
(wt%) 
Alginate: 
bioink 
(g) 
Water: 
alginate 
solution/gel 
(g) 
Alginate 
solution/gel: 
bioink (g) 
CLPs: 
bioink 
(wt%) 
CLPs 
related 
to CNF 
(wt%) 
CLPs: bioink 
(g) 
CNF-alginate 2.5 2.0 16 0.5 0.1 4.0 4.0 0 0 0 
T-CNF-alginate 2.0 1.9 19 0.5 0.1 9.0 1.0 0 0 0 
1% CLP-CNF-alginate 2.5 2.0 16 0.5 0.1 4.0 4.0 0.02 1 0.00400 
5% CLP-CNF-alginate 2.5 2.0 16 0.5 0.1 4.0 4.0 0.10 5 0.02000 
10% CLP-CNF-alginate 2.5 2.0 16 0.5 0.1 4.0 4.0 0.20 10 0.04000 
25% CLP-CNF-alginate 2.5 2.0 16 0.5 0.1 4.0 4.0 0.50 25 0.10000 
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6. Methods  
6.1. Rheology measurements  
Anton Paar MCR302 rheometer with the Anton Paar’s RheoCompass software was 
utilized for the rheology measurements. For these measurements, the parallel-plate 
geometry with both the serrated and plain bottom and upper plate was selected. The 
plate type used was PP25 with the diameter of 25 mm, and the gap between the 
plates was 1 mm. The serrated plates were used for the oscillatory amplitude sweep 
measurements to prevent the wall slip effect, whereas the dynamic viscosity 
measurements based on the shear forces were conducted with the plain plates. All 
the measurements were done in the temperature of 23 ˚C. The objective of these 
rheology measurements was to study the viscosities, shear-thinning properties, 
linear viscoelastic region (LVR), strength, and the viscoelastic nature of the bioinks to 
offer information about the printability of the bioinks and the effect of the different 
bioink compositions on the bioink characteristics.    
As mentioned before, two different measurements were conducted, dynamic 
viscosity and amplitude sweep measurements. The initial measurement set up and 
parameters were adjusted according to the article of Pääkkönen et al. (2016), and the 
measurements were repeated at least twice. In the dynamic viscosity measurement, 
the change in the dynamic viscosity, (Pa·s), values were recorded with the increased 
shear strain, 𝛾 (1/s), and the data obtained was used for the viscosity and shear-
thinning studies of the bioinks. The density of the bioinks was calculated for the 
measurement, and the applied strain varied between 0.01 1/s and 100 1/s. The 
density value for all the bioinks was ≈ 1 g/cm3.  
In the amplitude sweep measurement, the changes in the storage modulus, G’ (Pa), 
and loss modulus, G’’ (Pa), were recorded with the increased oscillatory strain, 𝛾 (1/s), 
and the data obtained was utilized to study the LVR, strength, and material type of 
these bioinks. This amplitude sweep measurement consisted of three intervals, which 
were preshear protocol, resting time, and the amplitude sweep test. The preshear 
protocol took for 3 minutes with 25 data points, constant measurement duration, at 
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the angular frequency of 𝜔 = 10 rad s-1, and at the strain amplitude of 𝛾 = 0.01 %. This 
was followed by the resting time for 10 minutes by steady state mode with one data 
point. The 3rd interval was the oscillatory test, in which the measurement was 
conducted using 25 data points, the steady state measurement duration, the 
constant frequency of 𝜔 = 1 rad s-1, and the varying strain amplitude of 𝛾 = 1 – 1000 
%. The used instrument and the measurement info are summarized in the Figure 15 
below.     
 
 
 
 
6.2. 3D bioprinting  
A 3D model in the shape of cylinder for 3D bioprinting was obtained from the website 
of Thingiverse (Anon. 2018), and customized using a 3D modelling software called 
OpenSCAD for the needs of the Master’s thesis. The dimensional tests for the 
hydrogels were conducted with the CNF-alginate and CLP-CNF-alginate bioinks. The 
final dimensions for the hydrogels were set to be 2.0 cm for the hydrogel height and 
1.5 cm for the hydrogel width, because the diameter of 1 cm was too small for 
Figure 15. A. A photo of the Anton Paar MCR302 rheometer. The bioink was placed in the centre of the upper and 
lower plates, firmly pressed in between them, trimmed, and measured. The measurements were based on either 
one-way shear or oscillatory operation, from which only the oscillatory amplitude sweep measurements were able 
to be repeated with the same bioink without the structural destruction. B. The serrated plates used for the 
amplitude sweep measurements to prevent the wall slip effect. The plain plates look similar but have a smooth 
surface. C. The measurements conducted for the bioinks. The dynamic viscosity measurement was used for 
studying the viscoelastic behavior of the bioinks, whereas the amplitude sweep measurement revealed, e.g., the 
nature and the inherent strength of these bioinks.  
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preventing the structure from collapsing with the CNF-alginate bioinks, whereas the 
maximum height obtained with the CLP-CNF-alginate bioinks was only 2 cm. The 
number of layers for the cylinder-shaped hydrogels were obtained from the equation 
(1) below. In these calculations, the tip diameter of 0.41 mm was used. The Figure 16 
below shows the appearance and info of the prepared 3D model used in 3D 
bioprinting, and the Equation (1) the calculations for the hydrogel layers. 
𝑇ℎ𝑒 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 ℎ𝑦𝑑𝑟𝑜𝑔𝑒𝑙 𝑙𝑎𝑦𝑒𝑟𝑠 =  
𝐻𝑦𝑑𝑟𝑜𝑔𝑒𝑙 ℎ𝑒𝑖𝑔ℎ𝑡 (𝑚𝑚)
𝑇𝑖𝑝 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 (𝑚𝑚)
=  
20 𝑚𝑚
0.41
= 48.7805 ≈ 49           (1)  
The bioprinter BioX from Cellink© was used for the 3D bioprinting process. The 
bioprinter consisted of alltogether 3 printheads. In this Master’s thesis, a 3 ml syringe 
was used. One bioink bottle prepared consisted of 20 ml of the bioink, which was 
required for the bioprinting of four to five cylinders with the height of 2.0 cm and 
width of 1.5 cm. In total, five bioprinted hydrogels per one bioink composition were 
needed for the further measurements. All the bioink compositions were bioprinted 
according to the same steps described next. The steps are also generally listed in the 
Figure 17 below. 
Figure 16. The 3D model prepared for 3D bioprinting with the OpenSCAD software. The height of the cylinder was 
2.0 cm, width 1.5 cm, and the number of layers within the cylinder 49. The structure was simple enough to be 
printed, but tall enough, so that the possible collapsing and other happenings during the storaging would be easier 
to detect. 
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Figure 17. The steps of 3D bioprinting and a photo about the 3D bioprinter. A. The BioX 3D bioprinter used in this 
Master’s thesis. B. The bioink was added into the syringe with a spoon. C. The bioink was syringed into the 3 ml 
3D bioprinting syringe. D. The syringe was placed into the specific printhead in the 3D bioprinter, followed by the 
addition of the petri dish and tip. E. After the required settings, the pressure was adjusted during the 3D bioprinting 
to ensure the desired hydrogel structure. F. After the 3D bioprinting, the hydrogels were photographed, crosslinked 
with 0.09 M CaCl2, and stored.  
The 3D bioprinting was started by gently adding some bioink with a spoon into a 
syringe, only carefully tapping the bioink to prevent the formation of the air bubbles. 
Next, the bioink was injected into the 3D bioprinting syringe with the volume of 3 ml 
and attached into a specific printhead in the 3D bioprinter. Petri dish was moved onto 
the printbead as a bioprinting platform, the tip of 0.63 mm was placed into the 
printhead, and the settings were adjusted. The pressure was controlled during the 
3D bioprinting according to the viscosity of the hydrogel.  
In the end of the 3D bioprinting, the obtained hydrogels for the free-standing 
measurements were photographed and cross-linked using 0.09 M CaCl2 solution in 5 
minutes. The other obtained hydrogels were also photographed and tentatively 
cross-linked using 0.09 M CaCl2 solution in five minutes, by adding a few drops of the 
solution on top of the hydrogels, and then pouring the hydrogels into the container 
containing 0.09 M CaCl2. The pouring cross-linked the whole hydrogel. The fully cross-
linked hydrogels immersed in the 0.09 M CaCl2 solution for the DMA were stored in 
the fridge for the next day, while the rest of the fully cross-linked hydrogels were 
removed from the 0.09 M CaCl2 solution and moved into the different storage 
conditions.    
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6.3. Storage methods    
The structural stability of the hydrogels after 3D bioprinting was measured using four 
different storage methods, including 1) humidity chamber, 2) freeze-drying and re-
wetting, 3) salt-water solution, and 4) free-standing. In the humidity chamber 
method, at least one hydrogel from all the bioink compositions was kept in the 
humidity chamber of RUMED© Rubarth Apparate GmbH in the temperature of 37 ˚C 
and in the relative humidity of 95% for seven days. In the freeze-drying method, the 
hydrogels were freeze-dried in the Freezone©2.5 from Labconco© in the vacuum 
conditions in the pressure of 0.700 mBar and temperature of -46 °C approximately 
for two days, until the frost and cold spots were completely disappeared from the 
outer layers of the hydrogels. These storage methods of humidity chamber and 
freeze-drying were adapted from Leppiniemi et al. (2017). After the freeze-drying, 
the hydrogels were eventually re-wetted by adding Milli-Q water and left to soak for 
overnight.  
In the case of the salt-water solution, at least one hydrogel from all the bioink 
compositions was held in the salt-water solution for seven days, whereas in the free-
stading method, the free-standing abilities of the hydrogels were measured by 
leaving them to stand on the table for 1 - 2 hours after the 3D bioprinting and cross-
linking with 0.09 M CaCl2. The composition of the salt-water solution has been 
described in more detail in the Subchapter 2.3. All the hydrogels from different 
storage methods were photographed and the dimensions were measured with a 
ruler before and after the storaging. This was followed by the evaluation of the 
structural changes, which is described in the Chapter 3. The different instruments 
utilized are also summarized in the Figure 18 below.    
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6.4. Dynamic mechanical analysis (DMA)  
The compression measurements of the 3D bioprinted hydrogels were conducted 
using the DMA – TA Instrument Q800. The compression measurements were 
conducted in 1 - 2 days after 3D bioprinting for the fresh, 3D bioprinted hydrogels 
and for the freeze-dried and re-wetted hydrogels. Before the DMA analysis, the 
hydrogels were rinsed with water to remove the excess cross-linking solution and cut 
by knife to reduce the hydrogel height to 1 cm. The maximum sample height in the 
DMA-TA Instrument was 1 cm.   
The DMA was started by calibration, which was followed by setting the parameters. 
In the TA Instrument Software, the mode was selected to be DMA controlled force, 
the test form custom, the clamp compression clamp and the sample shape a round 
disk. Furthermore, the dimensions of 10 mm as the hydrogel height and 15 mm as 
the hydrogel width were added, and the ramp force used was adjusted between 
0.500 N/min and 18 N/min.  
Next, the cutted hydrogels were placed into the DMA-TA instrument between the 
two plates using tweezers, the upper plate was prevented from moving, the furnace 
was closed, and the measurement was started. One measurement took 
approximately for 30 min. The described steps were repeated for each hydrogel, one 
hydrogel at a time. In addition, the parallel measurements were conducted in the 
Figure 18. A. Humidity chamber of RUMED© Rubarth Apparate GmbH. B. Freezone©2.5 from Labconco©. C. Salt-
water solution. D. A hydrogel exposed to room air.  
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case of all the hydrogel compositions. In the Figure 19, the DMA-TA instrument and 
the location of the cutted hydrogels in it are presented.  
 
 
 
 
 
 
RESULTS AND DISCUSSION  
7.  Preliminary tests   
Before the actual measurements were able to be started, a few preliminary tests had 
to be conducted. These preliminary tests considered the proper grid structure of the 
3D bioprinting hydrogels, and the preparation methods of the bioinks. The used grid 
structure has a significant effect on the appearance, resolution, and compression 
strength of the 3D bioprinted hydrogels and thus, the number of pores and the type 
of the grid structure had to be carefully chosen. On the other hand, the effect of 
sonication and centrifugation as the hydrogel pretreatment methods on the 
properties of the bioinks and hydrogels, e.g. stability, homogeneity, viscosity, and 
free-standing ability, was also important to be assessed.    
Figure 19. The photos revealing the DMA-TA Instrument Q800 and its operation principle. A. The measured 
hydrogel and an overall look of the DMA-TA instrument. B. The location of the measured hydrogel (1 cm) between 
the plates. After the hydrogel was placed between the plates and the furnace was closed, the measurement was 
started.  
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Figure 20. A. Sonicated (30 minutes) CNF-alginate bioink with the Sonorex Digitec ultrasonication bath from 
Bandelin, and 3D bioprinted with the pressure of 65 Pa, speed 10 mms-1, and infill of 28%. The photo has been 
taken before cross-linking with 0.09 M CaCl2. B. Centrifuged CNF-alginate bioink with the speed of 4000 rpm and 
time of 3 minutes, and 3D bioprinted with the pressure of 50 Pa, speed 8 mms-1, and infill of 28%. The photo has 
been taken after cross-linking with 0.09 M CaCl2. C. Centrifuged T-CNF-alginate bioink with the speed of 4000 rpm 
and time of 3 minutes, and 3D bioprinted with the pressure of 70 Pa, speed 12.8 mms-1, and infill of 28%. The photo 
has been taken before the cross-linking with 0.09 M CaCl2. D. The appearance of the grid structure with the infill 
of 28%.    
To begin, in 3D bioprinting, infill is the percentage parameter that is dependent on 
the type of the 3D printer device, featuring the type of a grid structure, and the 
number of the pores in the grid. The values from 0% to 100% were available in the 
settings of the used BioX 3D bioprinter. In this Master’s thesis, three different infill 
types of 25%, 28%, and 100% were tested and evaluated. Multiple tests were 
conducted for the sonicated and centrifuged CNF-alginate and centrifuged T-CNF-
alginate bioinks.  
The grid structure with the infill of 25% resulted only in four pores, whereas the grid 
structure with the infill of 100% contained too many small pores, which were clogged 
due to the swelling of the hydrogels. Both these grid structures had a negative effect 
on the appearance, resolution, and the compression strength of the 3D bioprinted 
hydrogels. However, the grid structure with the infill of 28% contained an adequate 
number of pores, which retained their shape well enough also after the swelling. 
Thus, the grid structure with the infill of 28% was decided to be used in the 3D 
bioprinting measurements. The participants of the grid structure tests with the best 
printing parameters and a schematic presentation about the grid structure with the 
infill of 28% can be seen in more detail in the Figure 20.   
 60 
 
When it comes to the hydrogel pretreatment methods, it was clear from the 
beginning that sonication alone was unable to remove the air bubbles or increase the 
homogeneity of the bioinks. The sonication times of 15 minutes, 30 minutes, 50 
minutes, and 1 hour and 30 minutes were tested. 15 minutes was too short a time, 
whereas after 50 minutes of continuous sonication, the bioinks easily burned, which 
also decreased their printability. In the case of the T-CNF, sonication as a 
pretreatment method was not enough, and resulted in bioinks with poor printability 
due to abundant air bubbles, inhomogenous bioink texture, and phase separation.    
Due to the poor performance of sonication, centrifugation was tested to remove air 
bubbles and to increase homogeneity of the bioinks. The centrifugation speed of 
4000 rpm and 2000 rpm and the centrifugation times of 1, 2, and 3 minutes were 
tested. Centrifugation clearly improved the homogeneity of the T-CNF- and CNF-
based bioinks, also removing the air bubbles, and the best results were obtained 
when the lower speed of 2000 rpm and time of 2 minutes were used. Nevertheless, 
the T-CNF-based bioinks could not be used in 3D bioprinting even after centrifugation 
due to the resulted, undesired bioink texture, unsuitable for 3D bioprinting.  
Therefore, as a conclusion, the infill of 28%, centrifugation speed of 2000 rpm, and 
time of 3 minutes, together with regular CNF as a material option were selected for 
the further measurements.  
8. Rheology   
8.1. Dynamic viscosity   
Dynamic viscosity measurements of the bioinks were conducted to assess their 
suitability to 3D bioprinting. The viscosity of the various bioinks increased as a 
function of increasing CLP content from 0% to 25% in the CLP-CNF-alginate bioinks 
(Figure 21 and Table 7). In addition, all the bioinks exhibited a shear-thinning 
behavior, in which the viscosity decreases with the increased shear rate, 𝛾 (1/𝑠), and 
shear stress, 𝜏 (𝑃𝑎). Shear-thinning is a typical feature of hydrogels and especially of 
all the thixotropic CNF-based bioinks (Lê et al., 2018; Metzger, 2015).    
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Figure 21. Effect of CLPs on the dynamic viscosity of the CLP-CNF-alginate hydrogels. The viscosity curves obtained 
from the dynamic viscosity measurements of the different bioink compositions. The curves have been plotted 
based on the mean values of two dynamic viscosity measurements.  
 
Table 7. The starting viscosities of the viscosity curves in the dynamic viscosity measurements. 
COMPOSITION STARTING VISCOSITY  
(MPa·s) 
CNF-ALGINATE 36.1 
1% CLP-CNF-ALGINATE 52.2 
5% CLP-CNF-ALGINATE 50.4 
10% CLP-CNF-ALGINATE 62.8 
25% CLP-CNF-ALGINATE 82.1 
 
Nevertheless, the viscosity curves of the Figure 21, are not a faultless half parabel, 
mostly in the case of the bioinks of CNF-alginate, 1% CLP-CNF-alginate, 5% CLP-CNF-
alginate, and 10% CLP-CNF-alginate. This can be due to the aggregates and thus 
inhomogeneity of the bioinks, air bubbles, problems with the bioinks, or errors during 
the dynamic viscosity measurements. The possible inhomogeneity and aggregation 
can be detected nearly in the same region with all the bioinks at lower shear rates. 
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Aggregates and inhomogeneity would also explain the variations in the amount of 
applied pressure of the same bioinks during 3D bioprinting. However, with the 
increased CLP concentrations of 5%, 10%, and 25%, the deviations can be detected 
also at higher shear rates, which can be due to the so-called dilatancy effect.  
The results are reasonable, because according to Lê et al. (2018), a strong shear 
thinning behavior can be detected in the case of all the CNF-lignin samples. On the 
other hand, the use of the lignocellulosic nanofibrils, LCNF, especially with a high 
lignin content of 17%, improves the viscosity of the lignin- and borax-containing, CNF-
reinforced polyvinyl alcohol hydrogels when compared to the pure CNF/PVA/Borax 
hydrogels (Bian et al. 2018). The literature findings also support the dilatancy theory. 
Again, according to Lê et al. (2018), the dilatancy at higher deformation were able to 
be detected in the case of all the CNF-lignin samples. The increase of this dynamic 
viscosity at higher deformation can be explained with the deformation-induced 
aggregation of the lower surface-charged and more flocculated and aggregated CNF 
suspensions containing lignin particles with glue-like properties. This reduces the 
freedom of movement. (Lê et al., 2018).   
On the other hand, the possible differences between the dynamic viscosity data and 
pressure changes may also have increased due to the various bioink bottles prepared 
at different times for the 3D bioprinting and dynamic viscosity measurements. 
Another explanation is the utilization of the different parts of the bioink, containing 
various number of CLPs, during 3D bioprinting. According to the Figure 21, the best 
bioink with the least aggregates is 25% CLP-CNF-alginate bioink which experiences 
also only a little bit variation when it comes to the 3D bioprinting pressure.    
8.2. Amplitude sweep 
The progress of the amplitude sweep measurement is the similar one in the case of 
all the bioinks (Figure 22). Linear viscoelastic region (LVR) can be detected, after 
which the whole bioink structure is eventually destroyed, and the material properties 
of the bioink are turned into a more fluid-like direction. Before this, the values of G’, 
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are greater when compared to the values of G’’. This indicates that the material 
measured is in a solid state, in more detail a gel-like mixture of dissolved alginate and 
dispersed CNF and CLPs, as expected in the case of the bioinks in the form of gel. All 
these results are in line with the earlier literature (Domínquez-robles et al., 2018; 
Metzger, 2015; Ribeiro et al., 2018).   
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Figure 22. Amplitude sweep curves with different CLP concentrations. The LVR, solid material type, span of critical 
strain (𝛾𝑐), and crossover point leading to structural destruction can be detected in the case of all the bioink 
compositions. 1. LVR. 2. The span of critical strain. 3. Crossover point.   
Nevertheless, the unlinearity of the amplitude sweep data after the LVR is a slightly 
surprising outcome. It can be due to the instabilities (Ewoldt, Johnston, & Caretta, 
2015), or the so-called wall slip effect in which the parallel plate cannot be in contact 
with the bioink in the desirable way during the measurement. Wall slip effect is a 
typical feature for the complex, thixotropic CNF-based materials (Lê et al., 2018). 
However, the measurements were repeated with the parallel plates with the rougher 
surface, which should restrict the wall slip effect (Ewoldt, Johnston, & Caretta, 2015), 
and the amount of air flow was restricted during the measurement using a plastic 
shield. In addition, bioinks which were less exposed to air were tested. Another 
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method would have been to add oil to the surface of the bioink to prevent the 
evaporation of water during the measurement, but there was not enough time for 
these tests.  
Nevertheless, the results were the same despite the repeated experiments and the 
varying methods. Thus, the surprising diagonal outcome is mainly not because of 
drying or wall slip effect. Another reason can be the inhomogeneity and aggregates 
of the bioinks, which were discussed already in the previous Subchapter of 8.1 in the 
case of the dynamic viscosity. On the other hand, this does not make sense either, 
because the aggregates are arbitrary, and the bioink behavior in the amplitude sweep 
measurement is always similar. Thus, most probably, the diagonal direction of the 
bioinks is due to the inherent bioink nature.  
Another explanation for the unlinear data of the bioinks is yielding and instabilities. 
Polymer solutions mixed with particles (suspensions) and metastable colloidal 
systems (e.g. gels) are considered as soft materials or yield stress fluids which face a 
transition between solid-like and fluid-like mechanical behavior due to the 
microstructural changes induced by the shear stress. This transition is called yielding. 
The yield state is directly associated with the existence of the plateau in quasi-steady 
flow curve. The flow curve is in many cases the consequence of a non-monotonic 
constitutive relation which can also be behind the unlinear region after the plateau 
LVR. This constitutive relation is difficult to be distinguished from the real slip of the 
sample at the wall, is unstable, and normally generates shear bandings or kinks in the 
data, especially in the case of G’’. Furthermore, the existence of material instabilities 
in shear flows during solid-fluid transition of soft matter systems is still an open 
subject and also a challenge. (Coblas, Broboana, & Balan, 2016). Thus, yielding, 
instabilities, and wall slip effect up to some degree may have influenced on the results 
of the present work.   
According to the Figure 22 and Table 11, the bioink of 1% CLP-CNF-alginate seems to 
resist the applied shear the most and thus, has the highest storage modulus indicating 
rigidity, before the bioink structure is completely broken up. With the increased CLP 
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concentrations, the resistance against shear stress first decreases remarkably, 
followed by the sudden increase in the case of the bioink of 25% CLP-CNF-alginate. 
The bioink of 5% CLP-CNF-alginate is clearly the weakest bioink. On the other hand, 
this strength distribution can also be seen from the length of the LVR, as evaluated in 
the Table 10. Thus, with the longer LVR, the bioink lasts longer before breaking up. 
This outcome is also in line with the literature findings. Lê et al. (2018) prepared CNF-
lignin films using lignin from different sources and various concentrations. They found 
out that the length of the LVR, or the span of critical strain, was higher for the films 
with lower residual lignin concentrations (Lê et al., 2018). The Table 15 considering 
the LVR together with the Table 16 evaluating the crossover points of the different 
bioinks can be found from the Appendix 2.    
When analyzing these strength results, through experience, the hydrogels with the 
increased CLP concentrations look and feel tougher and are less wobbly and less 
prone to fall over after 3D bioprinting. Thus, it would be logical that also the bioinks’ 
strength increases in the similar manner. On the other hand, the results are 
reasonable based on the following evaluation. During 3D bioprinting, the grid 
structure resolution of CNF-alginate hydrogel was the moderate one and increased 
considerably in the case of the 1% CLP-CNF-alginate hydrogel. However, when the 
CLP concentration was increased to 5% and 10%, the grid structure resolution 
suffered more often, and printing of a proper grid structure became harder and less 
smooth a process. On the other hand, when the CLP concentration was increased to 
25%, the grid structure resolution and printing smoothness were again enhanced, 
and the grid structure seemed even better than in the case of the regular CNF-
alginate hydrogel. Thus, the bioink strength studied in this amplitude sweep 
measurement is probably responsible for the grid structure resolution and even 
overall resolution of the 3D bioprinted hydrogels, and the easiness of printing 
considering resolution.  
The findings from the literature support these first slightly surprising results. Lê et al. 
(2018) realized that the lower surface charge and higher flocculation tendency of the 
lignin containing samples raise the viscosity and moduli of the suspension, which 
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results in a stiffer gel. This was proofed by the relation of G’/G’’ (Lê et al., 2018). The 
results of this Master’s thesis are approximately in line with this article, considering 
the 1% CLP-CNF-alginate and 25% CLP-CNF-alginate hydrogels. Therefore, the 
reliability of these results of the present work need to be considered, and repetition 
is recommended, because only one reportable measurement data of each bioink 
composition was obtained despite the repetition. Other possible explanations for the 
results are the inhomogeneous bioinks and the propensity of CLPs not to absorb as 
large quantities of water as CNF fibres or alginate.    
Elsewhere, Domínguez-robles et al. (2018) showed a clear tendency indicating that 
hydrogels that absorb a higher amount of water experience a lower storage modulus. 
According to the re-wetting results, which will be studied more thoroughly in the 
Subchapter 10.2, 1% CLP-CNF-alginate hydrogel with the highest bioink strength 
absorbed water the least, whereas 5% CLP-CNF-alginate with the lowest bioink 
strength and 10% CLP-CNF-alginate hydrogels absorbed water the most. According 
to this interpretation, the obtained results are reasonable.    
9. 3D bioprinting   
The earlier confirmed parameters of infill and speed in the Chapter 7 are used in this 
section. Therefore, these parameters were kept constant during 3D bioprinting, but 
the pressure needed to be changed to obtain the best structure for the hydrogels. 
Similar approach of changing pressure while keeping other parameters constant was 
also used by Shao et al. (2015) who 3D bioprinted MFC and LS containing hydrogels.  
When observing the values of pressure, which gave the best results during 3D 
bioprinting, between different hydrogel compositions, a clear increase in the 
pressure with increasing CLP content can be seen. This outcome is the expected one, 
because experience and dynamic viscosity measurements have shown that the 
addition of CLPs should increase the viscosity and thus also the amount of used 
pressure. Some variations in the pressure values occurred in the case of the CNF-
alginate and 5% CLP-CNF-alginate bioinks, whereas the bioinks containing other CLP 
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concentrations showed only two pressure values. The reason for this change in 
pressure can be, e.g., the propensity of the CNF-lignin material combination to cause 
flocculation and aggregation (Lê et al., 2018), and differences in the CLP distribution 
in the bioinks, as already evaluated in the Subchapter 8.1. The 3D bioprinting 
parameters and their studies are summed up in the Table 8.   
Table 8. 3D bioprinting parameters in the case of the different bioink compositions. 
MATERIALS INFILL (%) BEST PRESSURE  
(Pa)   
AVERAGE PRESSURE 
(Pa)  
SPEED 
(mms-1) 
CNF-ALGINATE 28 22 23 11.5 
1% CLP-CNF-ALGINATE 28 29 32.5 11.5 
5% CLP-CNF-ALGINATE 28 32 30.4 11.5 
10% CLP-CNF ALGINATE 28 26 28 11.5 
25% CLP-CNF-ALGINATE 28 35 33.5 11.5 
 
When evaluating the visual and experimental observations of the 3D bioprinted 
hydrogels, the hydrogels seem to become stronger and stiffer with the enhanced 
resolution, when the CLP concentration increases. Resolution means the high 
hydrogel surface fidelity, in which the different layers of the hydrogel and the pores 
of the grid structure can accurately be detected. Furthermore, the colour of the 
hydrogels change into more brown-like direction. The hydrogels of CNF-alginate and 
1% CLP-CNF-alginate are very similar with each other, wobbly, soft, and prone to 
collapse when touched or moved after 3D bioprinting. The bionks of these hydrogels 
are harder to handle, and air bubbles exist more easily than in the case of the bioinks 
with the higher CLP concentrations. However, the grid structure is easier to make 
with the 1% CLP-CNF-alginate hydrogel than with the 5% CLP-CNF-alginate and 10% 
CLP-CNF-alginate hydrogels. The best results are obtained with the bioinks with the 
CLP concentration of 25%. The appearance of the different 3D bioprinted hydrogels 
and the effect of the increased CLP concentration can be seen more thoroughly in 
the Figure 23, and photos considering 3D bioprinting repeatability in the Figure 24.  
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Figure 24. Photos considering the 3D bioprinting repeatability of the hydrogels with various compositions. The 
scale bar in the lower right corner refers to the marking on the petri dish. The length of that line is 1 cm.   A1. CNF-
alginate hydrogel number 1. A2. CNF-alginate hydrogel number 2. A3. CNF-alginate hydrogel number 3. B1. 1% CLP-
CNF-alginate hydrogel number 1. B2. 1% CLP-CNF-alginate number 2. B3. 1% CLP-CNF-alginate hydrogel number 3. 
C1. 5% CLP-CNF-alginate hydrogel number 1.  C2. 5% CLP-CNF-alginate hydrogel number 2. C3. 5% CLP-CNF-alginate 
hydrogel number 3.  D1. 10% CLP-CNF-alginate hydrogel number 1.  D2. 10% CLP-CNF-alginate hydrogel number 2.  
D3. 10% CLP-CNF-alginate hydrogel number 3. E1. 25% CLP-CNF-alginate hydrogel number 1. E2. 25% CLP-CNF-
alginate hydrogel number 2.  E3. 25% CLP-CNF-alginate hydrogel number 3. 
Figure 23. Photos of printed samples with various hydrogel compositions before and after cross-linking. The scale 
bar in the lower right corner refers to the marking on the petri dish. The length of that line is 1 cm.  A1. CNF-alginate 
before cross-linking. A2. CNF-alginate after cross-linking. B1. 1% CLP-CNF-alginate before cross-linking. B2. 1% CLP-
CNF-alginate after cross-linking. C1. 5% CLP-CNF-alginate before cross-linking. C2. 5% CLP-CNF-alginate after cross-
linking. D1. 10% CLP-CNF-alginate before cross-linking. D2. 10% CLP-CNF-alginate after cross-linking. E1. 25% CLP-
CNF-alginate before cross-linking. E2. 25% CLP-CNF-alginate after cross-linking.  
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As it can be seen from the Figure 24, the repeatability of the CLP-CNF-alginate 
hydrogels with different CLP concentrations is very good. The shape is well retained 
during and after 3D bioprinting, the grid structure is easy to make, and it is possible 
to 3D bioprint a tall hydrogel structure. The repeatability considering volume is also 
good, especially with the CLP concentration of 25%. This can be seen in the Figure 25. 
However, the maximum height of the hydrogels decreases with the increased CLP 
concentrations. It seems that due to the increased viscosity and thickness of the CLP-
CNF-alginate bioinks, probably because of the bioinks’ propensity to cause 
agglomerates, more bioink is needed to bioprint the hydrogel with the same size 
when compared to the regular CNF-alginate bioink.  
In the case of the regular CNF-alginate and 1% CLP-CNF-alginate, the maximum height 
obtained is 2.5 cm. With the increased CLP concentrations, the maximum height 
obtained is decreased to 2 cm. Furthermore, the maximum height was not possible 
to obtain in the case of all the 3D bioprinted hydrogels, due to the variations in the 
bioinks of the same concentration and technical malfunctions during the 3D 
bioprinting, such as clogging of the 3D bioprinting needle. The height of the hydrogels 
varied between 1.2 and 2 cm. However, the height of most of the 3D bioprinted 
hydrogels is around 2 cm.  
Figure 25. The average hydrogel volumes (cm3) and standard deviations (%), revealing the hydrogel repeatability 
in 3D bioprinting. 4 - 5 hydrogels per each hydrogel composition was utilized. The calculations can be seen in the 
Appendix 4. 
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The combination of the CNF-alginate bioink with the increased CLP concentrations 
systematically improved the printability and shape stability during and after 3D 
bioprinting. In addition, all the CLP containing hydrogels held their pristine geometry 
after the bioprinting. This outcome is most probably due to the nanoscale size of the 
CNF and CLPs and the existence of alginate which increases the viscosity of the 
bioinks and forms physical cross-links between the CNF fibres. According to Hossen 
et al. (2018), cross-linking between methacrylate groups provided structural stability 
for the CNF-MetCMC gels in the aqueous environment. The effect of cross-linking can 
also be the situation in the case of the CNF fibres and alginate. This effect of cross-
linking with CaCl2 can be seen more thoroughly in the Figure 26 below.       
Figure 26. A schematic presentation (not drawn to scale) about the effect of cross-linking with CaCl2 on the 
molecular level. A. Before cross-linking, the dispersion contains separate CNF fibres and soluble alginate. B. Soluble 
alginate is wrapped around the surface of the CNF fibres. C. After cross-linking, Ca2+ ions have formed physical 
cross-links with alginate covering the surface of the CNF fibres.     
The high hydrogel resolution observed is most probably interlocked with the 
increased CLP concentration and bioink strength.  This can especially be seen in the 
case of the 25% CLP-CNF-alginate and 1% CLP-CNF-alginate hydrogel. As shown in the 
Figure 24, the grid structure resolution was good in the case of the CNF-alginate 
hydrogel, improved with the 1% CLP-CNF-alginate hydrogel, and as good or even 
better in the case of the 25% CLP-CNF-alginate hydrogel. Therefore, the observation 
of the best resolution in the case of the 25% CLP-CNF-alginate hydrogel is probably 
due to the high mechanical strength, discussed in more detail in the Chapter 11, 
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combined with the high bioink strength. Therefore, in general, the results with these 
3D bioprinted CNF-alginate and CLP-CNF-alginate hydrogels are reasonable.  
On the other hand, according to Vedadghavami et al. (2017), the mechanical 
properties of the hydrogels have been increased with nanoparticles and the use of 
nanoparticles has increased for example the compression strength of the hydrogels 
even to 90%.  Elsewhere, Raschip et al. (2013) manufactured xanthan/lignin 
hydrogels with higher stability due to the incorporation of lignin, using 
epichlorohydrin as a cross-linking agent in an alkaline medium with different types of 
lignin. Further, Si et al. (2017) prepared cellular-structured nanofibrous hydrogels 
(NFHs) by combining alginate and flexible SiO2 nanofibres, in which the fragile 
appearance and shrinking during cross-linking due to water absorption of the CNF-
alginate hydrogels was avoided by the addition of SiO2 nanofibres. SiO2 nanofibres 
supported the hydrogels and prevented them from collapsing (Si et al., 2017). Last 
but not least, lignin also makes wood fibres stiff and strong, acting like a glu between 
the individual fibres (Reeb, 1998). Therefore, in the case of the CLP-CNF-alginate 
hydrogels, it is reasonable that the addition of lignin increases the stability and the 
feel of stiffness and toughness and decreases the wobbliness of the hydrogels, 
preventing them from collapsing when moved. These results are important because 
the material combination of CLP-CNF-alginate have not been tested before for 3D 
bioprinting, no earlier studies are available, and a few studies combining different 
type of lignin with nanocellulose have shown undesired results.   
10. Structural rigidity in various environments    
10.1. Structure retention in freeze-drying    
After 3D bioprinting, various bioprinted hydrogels were moved into the different 
storage conditions. The results from the freeze-drying process are first evaluated. It 
can be seen from the photos in the Figure 27, that all the hydrogels, from the CNF-
alginate to the CLP-CNF-alginate hydrogels with the different CLP concentrations, 
significantly shrank due to the freeze-drying process. The surface of the freeze-dried 
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hydrogels appeared very jagged and rough when compared to the hydrogels before 
the freeze-drying process. The most jagged hydrogel is the CNF-alginate, in which 
small parts of the surface are even peeling off when touched. The roughness of the 
surface decreased when the CLP concentration increased. With the CLP 
concentration of 25%, the surface became more homogenous.   
The feel of stiffness and toughness increased with the increased CLP concentrations. 
For example, the CNF-alginate hydrogel seemed very fragile when handled. On the 
other hand, the hydrogels with the CLP concentrations of 10% and 25% appeared 
tougher and even stiffer and did not deteoriate when pressed with fingers. On the 
other hand, the initial shape of the hydrogels seemed to last differently during freeze-
drying with the different hydrogel compositions. The CNF-alginate and 25% CLP-CNF-
alginate hydrogels resembled more their initial versions when compared to the other 
freeze-dried hydrogels. According to the photos, the shape of the hydrogels changed 
the most at CLP concentrations of 5% and 10%. The appearance, shrinking behavior, 
and possible dimensional changes of the hydrogels can be seen in more detail in the 
Figure 27 below.      
In the case of the dimensional changes, it can be seen from the percentage data in 
the Figure 28 that with the smaller CLP concentrations of 1% and 5%, hydrogels 
shrank the least both in the longitudinal and lateral direction. The smallest changes 
occured with the hydrogel at 5% concentration of CLPs. On the other hand, hydrogels 
shrank the most with the higher CLP concentrations of 10% and 25%. The biggest 
changes in dimensions occurred with 10% CLPs. The shrinking behavior of the CNF-
alginate was between the lower CLP concentrations of 1% and 5% and the highest 
CLP concentrations of 10% and 25%. Thus, it can be said that CLPs have an influence 
on the shrinking behavior of the hydrogels when it comes to the dimensional stability. 
The hydrogels with the highest CLP concentrations shrink more when compared to 
the hydrogels with the lower CLP concentrations.   
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Figure 28. The overall longitudinal and lateral dimensional changes of the hydrogels in the form of percentages 
(%), when the freeze-dried hydrogels were compared to the ones directly after 3D bioprinting. 
 
 
 
 
 
 
 
 
 
 
Figure 27. Photos considering the different hydrogels with various hydrogel compositions before and after freeze-
drying. The scale bar in the lower right corner refers to the marking on the petri dish. The length of that line is 1 
cm. A1. CNF-alginate hydrogel before cross-linking with 0.09 M CaCl2. A2. CNF-alginate hydrogel after cross-linking. 
A3. CNF-alginate hydrogel after freeze-drying.  B1.  1% CLP-CNF-alginate hydrogel before cross-linking.  B2. 1% CLP-
CNF-alginate hydrogel after cross-linking.  B3. 1% CLP-CNF-alginate hydrogel after freeze-drying. C1. 5% CLP-CNF-
alginate hydrogel before cross-linking.  C2. 5% CLP-CNF-alginate hydrogel after cross-linking.  C3. 5% CLP-CNF-
alginate hydrogel after freeze-drying.  D1. 10% CLP-CNF-alginate hydrogel before cross-linking.  D2. 10% CLP-CNF-
alginate hydrogel after cross-linking. D3. 10% CLP-CNF-alginate hydrogel after freeze-drying. E1. 25% CLP-CNF-
alginate hydrogel before cross-linking. E2. 25% CLP-CNF-alginate hydrogel after cross-linking.  E3. 25% CLP-CNF-
alginate hydrogel after freeze-drying.  
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The shrinking behavior observed in the current work with CLP-CNF-alginate hydrogels 
is reasonable. Passauer, Fischer, & Liebner (2011) studied lignin hydrogels with 
moderate shrinking properties, which indicates that one feature of the lignin-based 
hydrogels is clearly shrinking. Furthermore, lignin naturally regulates shrinking 
behavior of wood. When shrinking occurs in the natural wood, water escapes 
between the microfibrils, containing cellulose and hemicellulose molecules (Reeb, 
1998). As water leaves, the microfibrils come closer together and thus, shrinking 
occurs mainly in the lateral direction (Reeb, 1998), in more detail, in the tangential or 
radial direction (Bonarski, Kifetew, & Olek, 2015). Tangential shrinkage is usually 1.5 
– 2.5 times that of the radial shrinkage (Bonarski, Kifetew, & Olek, 2015). Longitudinal 
shrinkage also occurs, but it is usually very small, only from 0.1 % to 0.2% (Bonarski, 
Kifetew, & Olek, 2015; Reeb, 1998).  
In the basic level, long CNF fibres give strength to the structure, whereas alginate 
offers, among other things, increased swelling properties and CLPs act, e.g., as solid 
particles also giving strength to the gel. Nevertheless, the major difference in the 
shrinking behavior of the CLP-CNF-alginate hydrogels, when compared to the natural 
wood, is the more pronounced shrinking of these hydrogels also in the longitudinal 
direction with the increased CLP concentrations. This phenomenon must be related 
to the nano-size of the CNF and CLPs and the non-organized structure of the 
hydrogels in comparison to natural wood.     
This theory could be reasonable, because according to Stocco et al. (2018), the degree 
of attachment of modulatory molecules is greater along the surfaces of the 
nanofibrous substrates than along flat surfaces. Thus, having densely packed specific 
molecules along the nanofibrous periphery is possible. Furthermore, the nano-size of 
the CLPs increases the number of attached particles and the influence of them. This 
theory would also be in line with the increased stiffness of the CLP-CNF-alginate 
hydrogels with the increased CLP concentrations.   
More evidence can also be found from the literature to support these inferences. 
SEM images of the freeze-dried NFC aerogels revealed that at higher lignin 
 75 
 
concentrations, the surface of the fibrils are rougher with the coarse, globular lignin 
particles (Lê et al., 2018). Lê et al. (2018) also stated that even if the lignin 
nanoparticles adsorb on the surface, some of the particles can also be found from the 
surroundings. Evidence can also be found considering the type of interactions 
between the CNF fibres and CLPs, and, on the other hand, between the individual 
CLPs. These interactions could be based on the hydrogen bonds between the CNF 
fibres and phenolic and aliphatic hydroxyl groups of lignin, as suggested by 
Jayaramudu et al. (2019), who studied the interactions of the CNF films and combined 
PEO and lignin material (PEO-L), based on the FTIR observations.  
On the other hand, according to the 13C and 31P NMR spectroscopy measurements 
performed by Sipponen et al. (2018), softwood kraft lignin (SKL) contains 
approximately 0.74 mmol/g conjugated or non-conjugated carboxylic acid groups 
which most probably interact with CNF fibres. Nevertheless, in SKL, hydroxyl groups 
are the most predominant ones, with phenolic hydroxyl groups being the most 
abundant (Sipponen, et al. 2018). This is most probably the case also with the CLPs. 
In the Figure 29 below, a schema about the possible electrostatic interactions 
between CNF fibres and CLPs can be seen, whereas in the Figure 30, the interactions 
between CLPs and alginate after cross-linking with 0.09 M CaCl2 have been presented.   
Figure 29. The scheme (not drawn to scale) about the possible interactions between the CNF fibres and CLPs. A. 
The chemical structure of lignin. B. The chemical structure of CLP, together with the pure CNF fibres and CNF fibres 
completely or partially surface wrapped with alginate. C. The hydrogen bonds between the hydroxyl and carbxylic 
 76 
 
acid groups of the CLPs and hydroxyl groups of the pure CNF fibres and CNF fibres partially surface wrapped with 
alginate. (Adapted from Domínguez-robles et al. (2018) and Sipponen et al. (2018)).   
Figure 30. The scheme (not drawn to scale) about the cross-linking of CNF fibres, completely or partially surface 
wrapped with alginate, and CLPs with 0.09 M CaCl2. A. CNF fibres, together with the soluble alginate and CLPs, 
before cross-linking with 0.09 M CaCl2. B. CNF fibres, completely or partially surface wrapped with alginate, form 
physical cross-links with CLPs with the aid of Ca2+ ion.   
Therefore, it is prominent that at the lower CLP concentrations, CLPs exist at small 
amounts both in between and on the surface of the CNF fibres, disturbing the natural, 
interfibrillar CNF bonds and restricting the fibres getting closer to each other. This, in 
turn, decreases the shrinking. However, at the higher CLP concentrations, the 
number of the CLPs on the surface of the CNF fibres increases, covering the surface 
more thoroughly, and more hydrogen bonds between the CNF fibres and CLPs and 
cross-links between the CLPs and alginate are formed, balancing the initial, disturbed 
hydrogen bonds. Furthermore, the non-bound CLPs between the fibres may allow an 
increase in the water absorption into spaces (pores) between the CNF fibres, giving 
more space for the hydrogel structure to swell and, oppositely, shrink. Therefore, the 
increased amount of bound and non-bound CLPs, different bonds, the existence of 
pores, and the nano-size of the CLPs enhance the shrinking behavior and absorbency 
of the CLP-CNF-alginate hydrogels.             
10.2. Water absorption in re-wetting   
When looking at the Figure 31 below and analyzing the appearance of the hydrogels 
based on the photos, it can be stated that the hydrogels of the CNF-alginate, 10% 
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CLP-CNF-alginate, and 25% CLP-CNF-alginate have retained their initial shape the 
best. In addition, it seems that they have absorbed water the most, which can be 
seen from their surface. The surface of the hydrogels does not seem as dry and fragile 
as in the case of the hydrogels with the CLP concentrations of 1% and 5% when they 
are compared to their initial, freeze-dried hydrogels.    
However, the exact dimensional changes are slighly difficult to interpret only from 
the photos. The CNF-alginate hydrogel has clearly absorbed water and swollen, the 
10% and 25% CLP-CNF-alginate hydrogels have absorbed some amounts of water and 
faced dimensional changes, whereas the width of the hydrogel of 5% CLP-CNF-
alginate has considerable decreased. After the re-wetting, the hydrogels became 
softer and moist, but still tougher when compared to the initial hydrogels before 
freeze-drying. The feel of toughness and stiffness increased with the increased CLP 
concentrations even with the re-wetted hydrogels.  
Figure 31. The photos revealing the different hydrogels with various hydrogel compositions before and after re-
wetting. The scale bar in the lower right corner refers to the marking on the petri dish. The length of that line is 1 
cm. A1. CNF-alginate hydrogel after freeze-drying. A2. CNF-alginate hydrogel after re-wetting. B1. 1% CLP-CNF-
alginate hydrogel after freeze-drying. B2. 1% CLP-CNF-alginate hydrogel after re-wetting. C1. 5% CLP-CNF-alginate 
hydrogel after freeze-drying. C2. 5% CLP-CNF-alginate hydrogel after re-wetting. D1. 10% CLP-CNF-alginate 
hydrogel after freeze-drying. D2. 10% CLP-CNF-alginate hydrogel after re-wetting. E1. 25% CLP-CNF-alginate 
hydrogel after freeze-drying. E2. 25% CLP-CNF-alginate hydrogel after re-wetting.   
The studies considering the dimensional changes are in line with the interpretations 
made based on the hydrogel photos. The Figure 32 below reveals that the hydrogels 
with the highest CLP concentrations of 10% and 25% had swollen the most, nearly 
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Figure 32.  The overall longitudinal and lateral dimensional changes of the hydrogels in the form of percentages 
(%), when the re-wetted hydrogels were compared to the ones directly after freeze-drying. 
  
 
reaching the initial dimensions of these hydrogels. In contrast, the length or width of 
the hydrogels with the lowest CLP concentrations of 1% and 5% had sligthly 
decreased. In general, the hydrogels with the CLP concentrations of 1% and 5%, which 
shrank the least, also showed the lowest extent of water uptake, and the hydrogels 
with the CLP concentrations of 10% and 25%, which shrank the most, absorbed most 
water and thus swelled the most. The best performance can be seen in the case of 
the 10% CLP-CNF-alginate hydrogel, which swelled back to its initial dimensions after 
the freeze-drying and re-wetting. In the Figure 32, the dimensional changes of the 
various hydrogels can be observed in detail.  
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According to the literature, it is evident that the addition of lignin supports the 
absorption and swelling capacity of the other hydrogel components, in the case of 
the CLP-CNF-alginate hydrogels, the capacity of CNF fibres. The addition of lignin 
improved the swelling behavior of porous lignin-based poly(acrylic acid) hydrogel 
with higher water retention, fast swelling and deswelling rates (Ma et al., 2016). On 
the other hand, Larrañeta et al. (2018) prepared lignin hydrogels by combining lignin 
with poly (ethylene glycol) and poly(methyl vinyl ether-co-maleic acid) through an 
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esterification reaction. The prepared hydrogels showed swelling capabilities up to 
500% (Larrañeta et al., 2018). In another study, Domínguez-robles et al. (2018) 
prepared hydrogels by cross-linking poly(methyl vinyl ether co-maleic acid) and 
different technical lignins in ammonium and sodium hydroxide solutions. The 
resulted hydrogels experienced high water absorption capacities, ranging from 13 to 
130 g of water per 1 g of sample (Domínguez-robles et al., 2018). Furthermore, 
Raschip, Hitruc, & Vasile (2011) prepared biodegradable and superabsorbent xanthan 
and lignin containing hydrogels based on cross-linking between xanthan gum and 
lignin, using epichlorhydrin as a cross-linking agent in the alkaline NaOH medium. The 
produced hydrogels were biodegradable and had, e.g., combined antimicrobial and 
antioxidative properties with increased biocompatibility (Figueiredo et al. 2018).  
However, the process of freeze-drying has its own effect on the absorption and re-
wetting capacities of the hydrogels, as described below. According to Hossen et al. 
(2018), the larger pore volume in the highly porous gels allows hydrogels to hold 
more fluid. In their article, the amount of water retained inside the 3D structure 
increased linearly with the increasing porosity (Hossen et al. 2018). Therefore, it is 
likely that the freeze-drying process and the increased number of pores improves the 
re-wetting properties of the CLP-CNF-alginate hydrogels, also when compared to the 
basic drying method through evaporating.   
When taking a look at the molecular level, according to Domínguez-robles et al. 
(2018), the degree of swelling of the hydrogels is inversely related to the cross-linking 
density. Therefore, the decreased shrinking after freeze-drying and increased 
swelling after re-wetting with the increased CLP concentrations is not only due to the 
influence of the CLPs and the process of freeze-drying, but also the decrease of the 
hydrogen bonds between the individual CNF fibres. It can be that the increased 
number of CLPs adsorbed on the surface of the CNF fibres block the formation of the 
hydrogen bonds between the CNF fibres and the cross-links between the CNF fibres 
and alginate, even replacing some of the prior ones. This, in turn, enhances the 
absoprtion and re-wetting properties of the hydrogels. The influence of lignin on the 
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hydrogen bonds are also analyzed in the Chapter 10.1 considering the effect of 
freeze-drying process, and in the Chapter 11 about DMA of the hydrogels.        
10.3.  Hydrogel stability in humidity chamber    
In this storage method, the physiological conditions inside the human body 
considering humidity were mimicked and their influence on the hydrogel stability 
were monitored, by placing the studied hydrogels in the relative humidity of 95% and 
temperature of 37 °C. According to the photos in the Figure 33 below, a clear 
decrease in the height can be detected in the case of all the hydrogels. The height 
decreased nearly linearly, starting from the hydrogel of the CNF-alginate, and the 
hydrogel of the 10% CLP-CNF-alginate shrank also in the lateral direction. On the 
other hand, toughness and at the same time resolution increased and the hydrogels 
maintained their initial shape better with the increased CLP concentrations. The 
shape deformation was at worst in the case of the hydrogels of the CNF-alginate, 1% 
CLP-CNF-alginate, and 5% CLPs-CNF-alginate. Furthermore, the resolution of the 
hydrogels after humidity chamber increased in the case of the CLP concentrations of 
10% and 25%, when compared to their initial hydrogels, and the water vapor scraped 
down the rough edges of the hydrogel surfaces.   
After the humidity chamber, the hydrogels appeared tougher when compared to 
their initial hydrogels and were rubber-like when touched. The hydrogel with the 
highest CLP concentration of 25% already resembled of a hard rubber and 
deteriorated the least when handled. When compared to the other storage methods, 
humidity chamber gave the best visual effects on the hydrogels, in more detail, the 
appearance of the hydrogels suffered the least with the increased CLP 
concentrations. The appearance of the various hydrogels and the possible 
dimensional changes can be seen in the Figure 33, and the numerical data considering 
the dimensional changes of the hydrogels in the Figure 34.    
According to the data in the Figure 34, the humidity of 95% and temperature of 37 °C 
led to shrinkage in all the hydrogels. The longitudinal dimensional changes of the 
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hydrogels decreased by 5% when 1% of the CLPs was added to the CNF-alginate 
hydrogel composition. However, when the CLP concentration increased, the 
longitudinal dimensions of the hydrogels decreased nearly linearly. This decrease in 
height was also detected from the hydrogel photos. At the same time, the lateral 
dimensions remained essentially unchanged, except for the 25% CLP-CNF-alginate 
hydrogel. Despite the changes in height, the dimensional changes were generally 
smaller with every added CLP concentration when compared to the regular CNF-
alginate hydrogel. The best results were obtained with the CLP concentration of 1% 
in which the dimensional changes were the smallest. In general, the humidity 
chamber as a storage method increased the resolution, toughness, shape stability, 
and rubber-like appearance, but decreased the height and, in some cases, also the 
width of the hydrogels. The addition of CLPs into the CNF-alginate hydrogel 
composition clearly improved the structure retention under 95% relative humidity 
conditions.  
Figure 33. The photos of hydrogels with various compositions. The scale bar in the lower right corner refers to 
the marking on the petri dish. The length of that line is 1 cm.  A1. CNF-alginate hydrogel before cross-linking. A2. 
CNF-alginate hydrogel after cross-linking. A3. CNF-alginate hydrogel after humidity chamber. B1. 1% CLP-CNF-
alginate hydrogel before cross-linking. B2. 1% CLP-CNF-alginate hydrogel after cross-linking. B3. 1% CLP-CNF-
alginate hydrogel after humidity chamber. C1. 5% CLP-CNF-alginate hydrogel before cross-linking. C2. 5% CLP-CNF-
alginate hydrogel after cross-linking. C3. 5% CLP-CNF-alginate hydrogel after humidity chamber.  D1. 10% CLP-CNF-
alginate hydrogel before cross-linking. D2. 10% CLP-CNF-alginate hydrogel after cross-linking. D3. 10% CLP-CNF-
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Figure 34. The overall longitudinal and lateral dimensional changes of the hydrogels in the form of percentages 
(%), when the hydrogels exposed to the humidity chamber were compared to the ones directly after 3D bioprinting. 
 
alginate hydrogel after humidity chamber.  E1. 25% CLP-CNF-alginate hydrogel before cross-linking.  E2. 25% CNF-
alginate-CLPs hydrogel after cross-linking. E3. 25% CLP-CNF-alginate hydrogel after humidity chamber.  
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When analyzing the reliability of these results, the following analysis is obtained. In 
the case of the CNF-alginate hydrogel, the height and width of the hydrogel 
decreased about 2 mm. It seems that the combination of alginate and CNF restricted 
the swelling of the hydrogel but was unable to hinder the shrinking effect. These 
observations are in line with the ones found in the literature. Benselfelt, Engström, & 
Wagberg (2018) prepared CNF-alginate networks in which alginate was able to 
suppress the swelling of the CNF over 95%. In addition, according to the results of 
Leppiniemi et al. (2017), the cross-linked CNF-alginate hydrogels, which were pre-
conditioned in the room temperature, exhibited only a low extent of swelling when 
compared to the similar, freeze-dried hydrogel samples. Thus, the limited swelling is 
a reasonable effect. However, the hydrogel collapsed and showed 25% lower height 
compared to its initial height when kept for six days in the relative humidity of 95% 
and temperature of 37 ˚C (Leppiniemi et al., 2017). In the case of the measurement 
of this Master’s thesis, the height of the CNF-alginate hydrogel decreased 
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approximately 10% of its initial height. Thus, the obtained results are reasonable and 
better when compared to the literature findings, because CLPs help to maintain the 
structure stability of the hydrogels.    
Furthermore, Shankar, Reddy, & Rhim (2015) studied agar/lignin composite films, 
with the lignin concentrations of 1wt%, 3wt%, 5wt%, and 10wt%, in which the 
swelling ratio and moisture content was decreased with the increased lignin content, 
whereas Zadeh, Keefe, & Kim (2018) discovered that the addition of alkali lignin and 
lignosulfonate decreased the water vapor permeability of the soy protein isolate 
films to 50% of the control film. The strong intermolecular interactions between agar 
and lignin and therefore, good compatibility, increased the tortuous path for water 
vapor diffusion, resulting in less permeation of water molecules through the polymer 
film (Shankar, Reddy, & Rhim, 2015).    
10.4. Hydrogel stability in salt-water solution  
In this storage method, the hydrogels were placed in the salt-water solution, 
mimicking the salt composition used for the cell culture, and the structure stability of 
the studied hydrogels was evaluated. When observing the hydrogel photos in the 
Figure 35, the addition of CLPs clearly improved the shape and dimensional stability 
of the hydrogels in the salt-water solution. The shape of the CNF-alginate suffered 
the most with the small dimensional changes, but the shape and dimensions of the 
CLP containing hydrogels seemed nearly unchanged. In addition, the look and feel of 
toughness increased with the increased CLP concentrations.  
However, the undesired effect of the salt-water solution on the CNF-alginate and CLP-
CNF-alginate hydrogels was its disintegrating nature. The worst results were obtained 
in the case of the CNF-alginate hydrogel, which was close to impossible to handle due 
to its softness. It had also lost its shape nearly completely. With the lower CLP 
concentrations of 1% and 5%, the hydrogels remained soft, a small part of the surface 
had disintegrated, smoothing the surfaces, and the smaller defects in the hydrogel 
structure had enlargened.  
 84 
 
On the other hand, with the increased CLP concentrations, the disintegrating effect 
of the salt-water solution got even worse. In the case of the 10% CLP-CNF-alginate 
and 25% CLP-CNF-alginate hydrogels, the grid structure had considerably suffered, 
and the surface of the hydrogels had dissolved so much that it was difficult to detect 
single layers. 10% CLP-CNF-alginate hydrogel had dissolved the most, resulting in the 
softer surface which was prone to break up when handled. In the case of the 
hydrogels of the 25% CLP-CNF-alginate, the grid structure was nearly impossible to 
detect. Colour changes was also possible to detect in the case of the hydrogels with 
the CLP concentrations of 10% and 25%, which is probably due to the dissolution, 
dispersing, and possible dissolution of CLPs caused by the salt-water solution. The 
dissolution of CLPs was also able to be seen from the salt-water solution which colour 
was turned into slightly brown after the measurement. The appearance, effect of 
dissolution, and possible dimensional changes of the CNF-alginate and CLP-CNF-
alginate hydrogels can be observed in the Figure 35.   
Figure 35. The photos about the different hydrogels with various hydrogel compositions. The scale bar in the 
lower right corner refers to the marking on the petri dish. The length of that line is 1 cm.  A1. CLP-CNF-alginate 
hydrogel before cross-linking. A2. CLP-CNF-alginate hydrogel after cross-linking. A3. CLP-CNF-alginate hydrogel 
after salt-water solution. B1. 1% CLP-CNF-alginate hydrogel before cross-linking. B2. 1% CLP-CNF-alginate hydrogel 
after cross-linking. B3. 1% CLP-CNF-alginate hydrogel after salt-water solution.  C1. 5% CLP-CNF-alginate hydrogel 
before cross-linking. C2. 5% CLP-CNF-alginate hydrogel after cross-linking.  C3. 5% CLP-CNF-alginate hydrogel after 
salt-water solution. D1. 10% CLP-CNF-alginate hydrogel before cross-linking. D2. 10% CLP-CNF-alginate hydrogel 
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Figure 36. The overall longitudinal and lateral dimensional changes of the hydrogels in the form of percentages 
(%), when the hydrogels exposed to the salt-water solution were compared to the ones directly after 3D bioprinting. 
 
after cross-linking. D3. 10% CLP-CNF-alginate hydrogel after salt-water solution.  E1. 25% CLP-CNF-alginate hydrogel 
before cross-linking.  E2. 25% CLP-CNF-alginate hydrogel after cross-linking.  E3. 25% CLP-CNF-alginate hydrogel 
after salt-water solution.   
When, in turn, analyzing the dimensional changes of the hydrogels, it can be seen 
from the data in the Figure 36 that the salt-water solution decreased the dimensions 
of the CNF-alginate hydrogel but did not affect on the dimensions of the hydrogels 
with the various CLP concentrations. The addition of CLPs clearly prevented the 
dimensional changes of the hydrogels when exposed to the salt-water solution. In 
general, these hydrogels faced the least dimensional changes after the salt-water 
solution storage method when compared to the other storage methods. Therefore, 
this storage method has the best dimensional results. In the Figure 36 below, the 
dimensional changes of the hydrogels can be observed in more detail.  
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According to Abdelwahed et al. (2006), the major problem of nanoparticle systems is 
their poor stability in the aqueous medium. This major obstacle restricting the use of 
nanoparticles is due to the physical and the chemical instability, the chemical 
instability considering, e.g., hydrolysis of polymer materials forming the 
nanoparticles, and reactivity of materials during the storage (Abdelwahed et al., 
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2006). These instabilities are frequently noticed when the aqueous suspensions of 
nanoparticles are stored for an extended periods (Abdelwahed et al., 2006). 
However, at many circuimstances, CLPs are stable colloidal particles and not prone 
to hydrolysis reactions (Richter et al., 2016). CNF fibres are also reported to stabilise, 
e.g., diluted and concentrated dispersions, water-in-oil emulsions, and wet foams by 
forming a firm percolation fibril network (Tenhunen et al., 2018). Therefore, 
hydrolysis of the CLPs or CNF fibres alone should not be the case with the hydrogels 
of this Master’s thesis.    
On the other hand, other hydrogel properties and the composition of an aqueous 
medium has an influence on the hydrogel behavior. Kuo & Ma (2007) mentioned that 
instability of the ionically cross-linked hydrogels in an aqueous medium is a challenge. 
They found out that the hydrogel composition, when it comes to the dimensions of 
the Ca-alginate hydrogels, is dependent on the Ca+ ion concentration of the medium, 
cross-linking density, and polymer concentration of the gel. Shrinking or swelling 
occurs with too low or high Ca+ ion concentrations. On the other hand, also the 
hydrophilicity of Ca-alginate hydrogel increases the swelling behavior of this hydrogel 
in an aqueous medium in higher hydrogel concentrations (Kuo & Ma, 2007). 
Furthermore, according to Rol et al. (2018), also CNF fibres are highly hydrophilic.  
Thus, it is prominent that the combination of CNF-alginate in a hydrogel react when 
exposed to the salt-water solution, in a way described next. In the case of the 
hydrogel of CNF-alginate of this present work, it can be detected, that the hydrogel 
height and width decreased when the hydrogel was exposed to the salt-water 
solution. This can be seen in the Figure 36. However, when CLPs was added to the 
hydrogels, the dimensional changes stopped immediately. Only some small holes in 
the hydrogel structure deteoriated in the salt-water solution, until the deteoriation 
was stopped at higher CLP concentrations. This is reasonable, because the addition 
of lignin decreases the swelling ratio and moisture content of the material 
composites and hampers the diffusion rates (Shankar, Reddy, & Rhim, 2015), 
therefore, increasing the shape stability, as described in the previous Subchapter 
10.3. The increased shape stability is due to the increased attachment of the CLPs 
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onto the surface of the CNF fibres and the formation of hydrogen bonds, restricting 
the natural behavior of the CNF-alginate hydrogel, shrinking and swelling in the salt-
water solution.   
With the increased CLP concentrations, the hydrogel surface, in more detail the CLPs, 
started to dissolve due to the salt-water solution. This same phenomenon was faced 
by Lievonen et al. (2016), who utilized lignin extracted from the kraft pulping as in 
this Master’s thesis. In their work, the CLPs started to dissolve at pH 13, resulting as 
a yellowish colour of the CLP dispersion (Lievonen et al., 2016). Furthermore, the CLP 
dispersion became unstable at 1 M NaCl, which was due to the accumulation of Na+ 
counter ions around the CLPs and the consequent reduction of the thickness of the 
stabilising, electrical double layer, formed by CLPs (Lievonen et al., 2016).  Elsewhere, 
also Richter et al. (2016) experienced the dissolution of CLPs and limited dispersion 
stability at increased pH and aqueous NaCl concentrations, when high-purity CLPs 
were used. Therefore, in the case of this Master’s thesis, the dissolution of CLPs is not 
due to too high pH of the used salt-water solution, mimicking the physiological 
conditions inside the human body. However, the ionic concentration of, e.g., cationic 
sodium ions in the salt-water solution has most probably been too high for the stable 
CLPs. In general, according to the obtained results, CLPs are stable, colloidal particles 
up to certain limits in the CLP-CNF-alginate hydrogels, considering the number of 
CLPs in the hydrogels and the concentration of ions and the pH in the aqueous 
medium.          
10.5. Structure retention and drying in free-standing   
In this storage method, the hydrogels were kept on the table in the room air for the 
certain time, after 3D bioprinting and cross-linking with 0.09 M CaCl2, to evaluate the 
free-standing stability of the hydrogels. When looking at the hydrogels in the Figure 
37, the following observations based on these hydrogel photos and experimental 
observations can be made. It is rather evident that the smallest changes have 
occurred with the CNF-alginate hydrogel. The shape of the hydrogel and the length 
remained unchanged, only some slight collapsing was seen in the longitudinal 
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direction. In addition, drying could not be detected in the case of this reference 
hydrogel. Nevertheless, the addition of CLPs resulted in an increased swelling in the 
case of the hydrogel with the CLP concentration of 1%. This hydrogel had slightly 
swollen in the lateral direction.  
In the case of the hydrogels with the CLP concentrations of 5% and 10%, some major 
drying effects could be detected, especially in the upper parts of the hydrogels and 
around the grid structure. Drying can be seen for example as the colour changes. 
These hydrogels were also crumbled up in the longitudinal direction, which was 
resulted in an increased width in the central area of the hydrogels. However, the 
overall width of the hydrogels had not increased. In the case of the hydrogel with the 
CLPs concentration of 25%, the hydrogel had clearly started to crumble up and even 
to lose its shape, but no drying could be observed yet at this point. In addition, the 
resolution of this hydrogel seemed better when compared to the hydrogel of the CNF 
alginate or 1% CLP-CNF-alginate.   
The different time scale made it harder to interpret the differences between the 
various hydrogels. The free-standing times of the hydrogels were 1 hour and 5 
minutes for the CNF-alginate hydrogel, 1 hour and 15 minutes for the 1% CLP-CNF-
alginate hydrogel, 2 hours for the 5% CLP-CNF-alginate hydrogel, 1 hour and 50 
minutes for the 10% CLP-CNF-alginate hydrogel, and 1 hour for the 25% CLP-CNF-
alginate hydrogel. However, the hydrogels of the CNF-alginate, 1% CLP-CNF-alginate, 
and 25% CLP-CNF-alginate were photographed after approximately the same 
durations of free-standing. Thus, it can be stated that the CNF-alginate hydrogel 
changed the least, 1% CLP-CNF-alginate hydrogel faced increased swelling, and 25% 
CLP-CNF-alginate hydrogel started to lose its shape and height after approximately 1 
hour of free-standing in the air. In addition, with the increased free-standing times, 
the hydrogels with the increased CLP concentrations dried considerably. The 
appearance of the hydrogels, possible dimensional changes, and effect of drying can 
be seen more thoroughly in the Figure 37 below, together with the dimensional 
changes of the hydrogels in the Figure 38.     
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Figure 38. The overall longitudinal and lateral dimensional changes of the hydrogels in the form of percentages (%), 
when the hydrogels exposed to the room air were compared to the ones directly after 3D bioprinting. 
Figure 37. The photos about free-standing measurements of different hydrogels based on various bioink 
compositions. The scale bar in the lower right corner refers to the marking on the petri dish. The length of that line 
is 1 cm. A1. CNF-alginate hydrogel before cross-linking. A2. CNF-alginate hydrogel after cross-linking. A3. CNF-
alginate hydrogel after free-standing measurement. B1. 1% CLP-CNF-alginate hydrogel before cross-linking. B2. 1% 
CLP-CNF-alginate hydrogel after cross-linking. B3. 1% CLP-CNF-alginate hydrogel after free-standing 
measurement. C1. 5% CLP-CNF-alginate hydrogel before cross-linking. C2. 5% CLP-CNF-alginate hydrogel after 
cross-linking. C3. 5% CLP-CNF-alginate hydrogel after free-standing measurement. D1. 10% CLP-CNF-alginate 
hydrogel before cross-linking. D2. 10% CLP-CNF-alginate hydrogel after cross-linking. D3. 10% CNF-alginate-CLP 
hydrogel after free-standing measurement. E1. 25% CLP-CNF-alginate hydrogel before cross-linking.  E2. 25% CLP-
CNF-alginate hydrogel after cross-linking. E3. 25% CLP-CNF-alginate hydrogel after free-standing measurement.    
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The dimensional changes were also in line with the earlier observations based on the 
photos and experimental perceptions. According to the Figure 38 above, the most 
prominent dimensional changes occured with the hydrogels with the CLP 
concentrations of 5% and 10%, 10% CLP-CNF-alginate hydrogel having the biggest 
dimensional changes. On the other hand, the smallest dimensional changes occured 
in the case of the CNF-alginate hydrogel. Therefore, with the increased CLP 
concentrations and extended free-standing times, the hydrogel height decreased, 
and width increased due to the collapsing and drying of the CLP-CNF-alginate 
hydrogels.   
Generally, the CNF-alginate and 1% CLP-CNF-alginate hydrogels were more durable 
in comparison to the CLP-CNF-alginate hydrogel with the higher CLP concentrations 
after cross-linking with 0.09 M CaCl2 and left to stand freely on the table for 1 - 2 
hours. During this time, the CNF-alginate hydrogel slightly collapsed, and 1% CLP-
CNF-alginate hydrogel swelled more and more homogenously, both maintaining their 
moisture content. However, the dimensions did not considerably change. In contrast, 
the latter hydrogels with the increased CLP concentrations dried and slightly 
collapsed, especially from the upper parts of the hydrogels. At the same time, the 
bottom and central parts of the hydrogels slightly swelled, and the dimensions 
changed considerably. The hydrogels with the CLPs maintained their longitudinal 
dimensions worse than the CNF-alginate hydrogel when let to stand for 1 - 2 hours 
under ambient conditions (room temperature) after 3D bioprinting. The addition of 
CLPs clearly decreased the free-standing abilities of the hydrogels. Thus, when it 
comes to the overall appearance and drying of the hydrogels, CNF-alginate had the 
best properties when let to stand for 1 - 2 hours in the room air.       
These results are reasonable. Shao et al. (2015) prepared microfibrillated MFC and LS 
blend hydrogels which were air dried in the room temperature for five days, followed 
by the drying in the 110 °C oven for 48 h. The hydrogels with the LS concentrations 
of 0 wt%, 10 wt%, and 30 wt% faced extensive shrinking during the air drying, from 
which the 30 wt% MFC-LS hydrogel shrank the least, sligthly in the vertical direction 
with the rounded edges (Shao et al., 2015). Up to certain high lignin concentration, 
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in their article 50 wt%, the addition of lignin increased the effect of air drying, causing 
major shrinking (Shao et al., 2015). Furthermore, Hossen et al. (2018) found out that 
the presence of the CNF fibres in the hydrogels led to the increased shrinking during 
air drying, when the dried hydrogels of pure CNF, pure methylcellulose (MetCMC), 
and CNF-MetCMC were compared. According to the authors, this was probably due 
to the inadequate hydrophilicity of the CNF fibres (Hossen et al., 2018). Due to this 
poor hydrophilicity, the CNF containing hydrogels could not retain as much moisture 
inside them as, for example, CNF-MetCMC hydrogel. Therefore, in the case of this 
Master’s thesis, it is likely that the presence of CLPs in the CLP-CNF-alginate hydrogels 
increases the effect of drying and shrinking up to a certain limit.    
11. Dynamic mechanical analysis (DMA)    
The DMA was conducted for the CLP-CNF-alginate hydrogels with varying CLP content 
according to the instructions described earlier in the Subchapter 6.4. Nevertheless, 
the structural differences and density divergences in the hydrogels due to the varied 
3D bioprinting conditions to ensure the adequate hydrogel structure, influenced 
negatively on the DMA results. The obtained DMA results are unreliable because of 
this structural variation even between the hydrogels of the same bioink composition. 
Therefore, the results are not presented here, but attached in the Appendix 6.        
12. Conclusions   
According to the hypothesis, the addition of CLPs was expected to prevent the 
hydrogel shrinking upon drying. This was a partially correct assumption. The level of 
hydrogel shrinking upon drying was decreased with the lower CLP concentrations, 
after which the shrinking increased, reaching the maximum at 10% concentration of 
CLPs. The higher level of shrinking was also associated with the higher degree of re-
wetting. The benefits of these results, among others, are explained more thoroughly 
below.  
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The best hydrogels seem to be the 10% CLP-CNF-alginate and the 25% CLP-CNF-
alginate. The evaluation process can be seen in the Appendix 7. In this evaluation 
process, the hydrogels were ranked according to their performance in the different 
measurements described in the Chapters 8 - 11, and the hydrogels which faced the 
best performance most frequently were selected. The hydrogel with the CLP 
concentration of 10% possess a high viscosity, good repeatability and re-wetting 
properties, ability to keep its shape when exposed to the high moisture and salt-
water solutions, and good mechanical properties straight after 3D bioprinting and 
freeze-drying and re-wetting. The hydrogel of 25% CLP-CNF-alginate is very similar 
with the previous one, however, it has significantly better bioink strength. This 
improves the resolution of the 25% CLP-CNF-alginate hydrogel. Due to the better 
bioink strength and higher overall resistance of applied stress when it comes to 
stiffness, the 25% CLP-CNF-alginate hydrogel is also the toughest one when touched 
and the easiest to handle straight after 3D bioprinting. Unfortunately, in the case of 
these hydrogels, salt-water solution easily dissolves the hydrogel surface, in more 
detail the CLPs, and the hydrogels dry rather fast with considerable shrinking when 
let to stand in the room air.    
In the future, safety and functionality of these hydrogels with cells need to be 
researched together with the new material combinations to ensure the material 
safety and degradation rates inside the body. The problems of aggregation of the 
CLPs containing bioinks, salt-water deteoriation, and fast drying also need more 
research, considering, e.g., new biomaterials and the optimal ion concentration and 
pH in salt-water solution. Interesting would also be to test how the increase in the 
CLP concentration changes the hydrogel properties even more. On the other hand, 
the interactions of CNF, alginate, and CLPs on the molecular level would be good to 
ensure for example with the FTIR, and the effect of cross-linking between alginate 
and CNF fibres on the mechanical properties of the hydrogels, together with the 
possible non-monotonic constitutive relation in the CLP-CNF-alginate bioinks, require 
further research. Improvements for the future could also include the different and 
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better mixing techniques for the bioink preparation to ensure better CLPs 
spreadability and bioink homogeneity.    
Despite these drawbacks and requirements for the future research, 10% CLP-CNF-
alginate and 25% CLP-CNF-alginate hydrogels have a big potential to respond to the 
challenges of the biomaterials, e.g., lack of mechanical properties, and they could 
offer a promising, strong, and natural material option in the combination with other 
materials for the regeneration of hard tissues. These hydrogels are easy to process 
also with the fine details and are safe to handle during transportation and surgery. 
They maintain their shape more likely inside the body and can better tolerate the 
deteoriating body conditions, such as humidity and body fluids. On the other hand, 
the beneficial water uptake, swelling, and water retention properties of the light and 
porous freeze-dried CLP-CNF-alginate hydrogels make these hydrogels a reckoned 
candidate in the regeneration and mimicking of soft tissues with the requirement for 
good water uptake properties. CLP-CNF-alginate hydrogels could be an up-and-
coming alternative for the regeneration of kidneys in which the function of the 
kidneys is mainly focused on the water uptake and filtration abilities. In general, the 
many benefits of the CNF-alginate hydrogels with the higher CLP concentrations of 
10% and 25% make them a potential alternative as a new material combination for 
tissue engineering and regenerative medicine.  
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APPENDICES.   
APPENDIX 1.  
Calculations considering the dry matter content and yield of the cellulose and CLPs 
at the different preparation stages.  
 
Table 10. Dry weight analysis of the alkaline treated cellulose and the amount of moist cellulose required for 
TEMPO-oxidation. 
Aluminium cup (g) Sample (g) Aluminium cup + dm 
(g) 
Dm 
(%) 
Dry cellulose 
(g) 
For TEMPO-
oxidation (g) 
1.160 1.006 1.500 24 50 205.79 
 
Table 11. Dry weight analysis and yield of the TEMPO-oxidated cellulose. 
Aluminium cup (g) Sample (g) Aluminium cup + dm 
(g) 
Dm (%) Dry TEMPO-
cellulose (g) 
Yield (%) 
1.164 1.038 1.2975 1.298 41.1 82.11 
 
Table 12. Dry weight analysis and yield of the acid-treated TEMPO-oxidated cellulose. 
Aluminium cup 
(g) 
Sample 
(g) 
Aluminium cup + dm 
(%) 
Dm 
(%) 
Dry TEMPO-
cellulose 
Dry acid-
treated 
TEMPO-
cellulose 
Yield 
(%) 
1.149 1.036 1.417 25.92 4.106 3.732 90.90  
 
Table 13. Dry weight analysis of the CLP dispersion after the dialysis. 
Aluminium cup (g) 1 ml sample (g) Aluminium cup + dm (g) Dm (%) 
1.157 9.972 1.178 0.211 
 
Table 14. Yield of the CLPs after the freeze-drying.  
Lignin in (g) Empty bottle (g) Empty bottle + CLPs (g) Yield (%) 
2.288 54.04 57.091 75.0 
 
 
 
 
  
APPENDIX 2.  
Analysis of the LVR and crossover points of the bioinks in the amplitude sweep 
measurements.  
 
Table 15. Analysis of the LVR of the amplitude sweep measurement according to the storage modulus, G’ (Pa), 
based on the Figure 22.  
COMPOSITION LVR - START  
(Pa) 
LVR – END  
(Pa) 
LVR - Δ 
(Pa) 
CNF-alginate 2696.8 2916.5 219.7 
1% CLP-CNF-alginate 3168.9 3458.6 289.7 
5% CLP-CNF-alginate 2319.0 2531.1 212.1 
10% CLP-CNF-alginate 2413.0 2650.9 237.9 
25% CLP-CNF-alginate 3117.7 3420.7 303.0 
 
Table 16. Analysis of the crossover point of the storage modulus, G’ (Pa), and loss modulus, G’’ (Pa), curves of the 
amplitude sweep measurement, based on the Figure 22.    
COMPOSITION STORAGE 
MODULUS, G’  
(Pa) 
LOSS  
MODULUS, G’’  
(Pa) 
STORAGE 
MODULUS/ LOSS 
MODULUS 
(G’/G’’0.5%) 
SHEAR  
STRESS,  𝜸 
(Pa) 
CNF-alginate 82.582 80.929 0.00255 205.29 
1% CLP-CNF-alginate 98.301 96.409 0.00255 244.58 
5% CLP-CNF-alginate 65.995 68.673 0.00240 169.18 
10% CLP-CNF-alginate 71.821 74.083 0.00242 183.18 
25% CLP-CNF-alginate 87.833 90.502 0.00243 224.02 
 
 
 
 
 
 
 
 
  
APPENDIX 3. 
Data and calculations considering the changes in hydrogel dimensions after each 
storage conditions.  
Table 17. Dimensional data (cm) and changes (%) for the freeze-dried hydrogels. 
 
Table 18. Dimensional data (cm) and changes (%) for the re-wetted hydrogels. 
 
Table 19. Dimensional data (cm) and changes (%) for the hydrogels after salt-water solution. 
 
Table 20 and Table 21. Dimensional data (cm) and changes (%) for the hydrogels after humidity chamber and 
for the hydrogels after free-standing measurements.  
 
Composition Height (before) Height (after) Width (before) Width (after) %_height %_width 
CNF-alginate 2 1.7 1.5 1.2 -15  -20  
1% CLP-CNF-alginate 1.8 1.8 1.5 1.3 0 -13 
5% CLP-CNF-alginate 1.4 1.3 1.5 1.5 -7 0 
10% CLP-CNF-alginate 2 1.2 1.5 1.2 -40 -20 
25% CLP-CNF-alginate 2 1.5 1.5 1.4 -25 -7 
Composition 
Height (before) Height (after) Width (before) Width (after) %_height %_width 
CNF-alginate 1.7 1.9 1.2 1.4 12  17 
1% CLP-CNF-alginate 1.8 1.7 1.5 1.5 -6 0 
5% CLP-CNF-alginate 1.3 1.4 1.5 1.4 8 -7 
10% CLP-CNF-alginate 1.2 1.8 1.2 1.5 50 25 
25% CLP-CNF-alginate 1.5 1.8 1.4 1.5 20 7 
Composition Height (before) Height (after) Width (before) Width (after) %_height %_width 
CNF-alginate 1.9 1.8 1.5 1.3 -5 -13 
1% CLP-CNF-alginate 1.8 1.8 1.5 1.5 0 0 
5% CLP-CNF-alginate 1.2 1.2 1.5 1.5 0 0 
10% CLP-CNF-alginate 1.4 1.4 1.5 1.5 0 0 
25% CLP-CNF-alginate 2 2 1.5 1.5 0 0 
Composition Height (before) Height (after) Width (before) Width (after) %_height %_width 
CNF-alginate 2 1.8 1.5 1.3 -10 -13 
1% CLP-CNF-alginate 1.9 1.8 1.5 1.5 -5 0 
5% CLP-CNF-alginate 1.9 1.75 1.5 1.5 -8 0 
10% CLP-CNF-alginate 2 1.8 1.5 1.4 -10 -7 
25% CLP-CNF-alginate 2 1.7 1.5 1.5 -15 0 
Composition Height (before) Height (after) Width (before) Width (after) %_height %_width 
CNF-alginate 1.8 1.8 1.5 1.5 0 0 
1% CLP-CNF-alginate 1.8 1.8 1.5 1.6 0 7 
5% CLP-CNF-alginate 1.6 1.5 1.5 1.7 -6 13 
10% CLP-CNF-alginate 2 1.7 1.5 1.7 -15 13 
25% CLP-CNF-alginate 2 1.8 1.5 1.5 -10 0 
  
APPENDIX 4.  
Calculations considering the volume repeatability of hydrogels after 3D bioprinting.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Volume CNF-
alginate 
1% CLP-CNF-
alginate 
5% CLP-CNF-
alginate 
10% CLP-CNF-
alginate 
25% CLP-CNF-
alginate 
Average volume (cm3) 13.4 12.3 10.1 12.3 14.1 
Standard deviation 1.6 2.2 2.3 2.5 0.0 
Variance 2.5 4.9 5.5 6.4 0.0 
Standard deviation (%) 11.8  18.0  23.2  20.6  0.0  
Variance % 18.6  39.8  54.2  52.0  0.0  
Table 22. Calculations for the hydrogel repeatability in 3D bioprinting. 
  
APPENDIX 5. 
DMA results and their interpretation considering the CLP-CNF-alginate hydrogels 
with varying CLP content, 7 pp.    
 
In this Chapter, the ability of the different hydrogel compositions to restrict the 
applied sress during the DMA was evaluated. The obtained data consisted of the 
applied stress plotted against strain, displacement, and stiffness. Only the 
displacement and stiffness has been evaluated in this Chapter, due to the similarity 
of the strain and displacement. Strain and displacement stand for the deformation 
occurred during the DMA, whereas stiffness is the applied stress divided by the 
deformation. The Figures 39 and 40 summarize the mechanical behavior of the 
various hydrogels with different compositions. Later, the Table 9 and Figure 41 
summarize the numerical data considering Young’s modulus, E (N/m2), and slope, k 
(Ea/I0), based on the Figures 39 and 40. In the case of the stress-displacement curves, 
the three characteristic deformation stages typically found in cellular networks can 
be detected (Si et al., 2017). They are a linear or Hookean elastic regime with a 
Young’s modulus, a subsequent plateau stage, and a densification regime with the 
stress rising sharply (Si et al., 2017).  
When observing the displacement curves, (Figures 39 and 40), in the case of the 3D 
bioprinted hydrogels, more stress is needed to cause a displacement or, in other 
words, compression when hydrogels of 10% and 25% CLP-CNF-alginate are compared 
to the regular hydrogel of CNF-alginate. These CLPs containing hydrogels also have a 
smaller overall displacement in comparison to the CNF-alginate hydrogel, which is 
seen as the CLPs containing hydrogel curves reacting before the CNF-alginate 
hydrogel. On the other hand, less stress is needed to cause a displacement in the case 
of the 1% and 5% CLP-CNF-alginate hydrogels in comparison to the CNF-alginate 
hydrogel. The hydrogels of the 1% and 5% CLP-CNF-alginate are difficult to interpret 
only based on this Figure 39, requiring more repeated measurements, whereas the 
10% CLP-CNF-alginate hydrogel has the highest strength. In the case of the re-wetted 
and freeze-dried hydrogels, it is evident that the amount of applied stress needed to  
  
cause the compression has increased, which means a considerable increase also in 
the strength and stiffness of the hydrogels. The freeze-drying and re-wetting 
increases the mechanical strength of all the hydrogels and, at the same time, unifies 
the occurred displacement in the case of the individual hydrogels, CNF-alginate 
having the smallest and 10% CLP-CNF-alginate the highest amount of displacement.   
 
 
 
 
 
 
 
 
Figure 39. DMA results in the form of graphs of the 3D bioprinted hydrogels. The graph types of stress (MPa) vs. 
displacement (µm) and stress (MPa) vs. stiffness (N/m) have been used as an example.  
 
 
 
 
 
 
 
 
 
Figure 40. DMA results in the form of graphs of the freeze-dried and re-wetted hydrogels. The graph types of 
stress (MPa) vs. displacement (µm) and stress (MPa) vs. stiffness (N/m) have been used as an example.   
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Lastly, when having a look at the stiffness graphs (Figures 39 and 40), the amount of 
applied stress increases with the increased CLP concentrations. Furthermore, the end 
values of stiffness are in general higher with the 3D bioprinted CLP containing 
hydrogels than with the 3D bioprinted CNF-alginate hydrogel. Thus, it can be said that 
the hydrogels with CLPs are in the end stiffer than the CNF-alginate hydrogel, this 
result being in line also with the experimental observations after 3D bioprinting. 
However, the stiffness of the hydrogels does not increase sequentially. The stiffness 
of the hydrogel of 25% CLP-CNF-alginate is very close to the CNF-alginate hydrogel, 
followed by the hydrogel of 10% CLP-CNF-alginate. This is a surprising outcome, 
because according to the experimental observations, 25% CLP-CNF-alginate hydrogel 
is the toughest one. However, as mentioned in the Subchapter 8.2, a high bioink 
strength may be connected to the high hydrogel resolution. Therefore, the 
combination of high bioink strength, high resolution, average hydrogel strength and 
stiffness, and high overall resistance to the applied stress may result in the most 
stabile and toughest 25% CLP-CNF-alginate hydrogel observed by eye and touching. 
Another explanation can of course be small errors during the DMA.   
However, in the case of the freeze-dried and re-wetted hydrogels, all the hydrogel 
compositions behave nearly similarly when it comes to the stiffness in the DMA. The 
amount of applied stress has increased, so the hydrogels need more applied stress 
for the compression to occur. However, nearly all the applied stress needed to be 
consumed before the displacement or strain started to increase in the hydrogels. This 
indicates that the freeze-dried and re-wetted hydrogels are very strong and stiff.  
 
 
 
 
 
  
Table 9. Young’s modulus, E, (N/m2) and slope, k, (Ea/L0) for the hydrogels after 3D bioprinting and freeze-
drying and re-wetting. The highest values have been bolded. The calculations can be seen in the Appendix 6. 
COMPOSITION YOUNG’S 
MODULUS (Pa) – 
3D BIOPRINTING 
YOUNG’S 
MODULUS (Pa) – 
RE-WETTING 
SLOPE (k) – 3D 
BIOPRINTING  
SLOPE (k) – 
RE-WETTING 
CNF-ALGINATE 0,008 1,3*106 0,001 391,3 
1% CLP-CNF-alginate  121,2  1,8*106 7,1 545,5 
5% CLP-CNF-alginate  37,4 1,3*106 2,9 388,9 
10% CLP-CNF-alginate  2 946,7 133,3*106 208,3 6000,0 
25% CLP-CNF-alginate  1 456,0  4,3*106 
 
102,9 1625,0 
 
 
 
 
 
According to the Table 9 and Figure 41, the addition of CLPs increases the value of E 
and k of the bioprinted hydrogels, together with the re-wetted and freeze-dried  
According to the Table 9 and Figure 41, the addition of CLPs increases the value of E 
and k of the bioprinted hydrogels, together with the re-wetted and freeze-dried 
hydrogels, indicating the improved strength and stiffness. E stands for the mechanical 
strength, whereas k reveals the speed of the increase in this strength. Nevertheless, 
Figure 41. Data showing the variations in the young’s modulus, E, (MPa) of the hydrogels after 3D bioprinting and 
freeze-drying and re-wetting. A. The variations in the Young’s modulus, E, (MPa) of the hydrogels after 3D 
bioprinting. B. The variations in the Young’s modulus, E (MPa), of the hydrogels after freeze-drying and re-wetting. 
C. 3D bioprinted hydrogel after DMA. D. Freeze-dried and re-wetted hydrogel after DMA.     
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the exceptionally high peak in the hydrogel strength occurs in the case of the 10% 
CLP-CNF-alginate hydrogel, after which the hydrogel strength starts to decrease. This 
peak seems an outlier and overall, the values are slightly smaller when compared to 
the ones in the literature (Lê et al., 2018), which may be due to the errors, an 
unintentional neglicence for example in cutting the hydrogels, or the lack of 
repetition during the DMA. The measurements were conducted for the fresh, 3D 
bioprinted hydrogels twice and for the freeze-dried and re-wetted hydrogels only 
once due to the lack of time. Therefore, the reliability of these measurements may 
have suffered.  
The literature findings offer a slightly different approach. According to Bian et al. 
(2018), the addition of lignin to the CNF-films decreased their mechanical properties, 
considering tensile strength and Young’s modulus, probably due to the lignin’s ability 
to interfere the hydrogen bonds between the CNF fibres. The results are also in line 
with the ones obtained by Lê et al. (2018) who investigated that the increased CLP 
concentrations first increased and later systematically decreased the tensile strength 
and Young’s modulus of the LCNF films, the value of Young’s modulus being at its 
highest at the lignin concentration of 1.7% (Lê et al., 2018). Last but not least, in the 
article of Wang et al. (2016), the addition of lignin first slightly increased the Young’s 
modulus and thus mechanical properties, e.g. stiffness, of the chitosan fibres, 
followed by the maximun peak of E at around 3 wt%, and, in the end, a sharp decrease 
(Wang et al., 2016). The increase in E was due to the well dispersed lignin on the 
surface of the chitosan fibres, whereas the sharp decrease in E with the increased 
lignin concentration was caused by the agglomerations and thus, poor dispersibility 
of the lignin, which also reduced the contact between lignin and the chitosan fibres 
(Wang et al., 2016). However, the general strength and stiffness of the chitosan fibres 
were reported to be higher than the strength and stiffness of the chitosan fibres 
alone (Wang et al., 2016), likewise in this Master’s thesis.  
Therefore, in the case of the CLP-CNF-alginate hydrogels of the present work, it is 
evident that the addition of CLPs increases the mechanical strength and stiffness of 
the hydrogels, while the agglomeration and poor dispersibility of the CLPs onto the 
  
CNF fibres with the high CLP concentrations decrease the mechanical strength of the 
hydrogels up to certain extent. Nevertheless, the timing and the intensity of this 
decrease in mechanical strength due to the interference of the hydrogen bonds 
between the CNF fibres or agglomeration of CLPs is unclear. In the Chapter 9, it was 
already evaluated that the covalent bonds between alginate and the CNF fibres are 
formed after cross-linking with 0.09 M CaCl2. In the previous reference articles, the 
studies were performed only between lignin or CLPs and CNF fibres, without this third 
material. Therefore, it is logical that the existence of alginate and the covalent bonds 
hinder the interfering effect of CLPs and the agglomeration of CLPs onto the CNF 
fibres, at the same time maintaining the mechanical strength and stiffness of the 
hydrogels for longer periods. This would most probably move the decrease in 
mechanical strength to the higher CLP concentrations. This transfer can already be 
seen in the present work, because the significant decrease in the mechanical strength 
occurred with the CLP concentration of 25%, whereas for example in the article of Lê 
et al. (2018), this decrease took place already at lignin concentration of 3.1% and 
4.9%. However, more studies and more repetition need to be conducted to ensure 
the exact effect of covalent bonds between alginate and the CNF fibres on the 
mechanical properties of CLP-CNF-alginate hydrogels.     
When having a closer look at the Table 9 and Figure 41, the Young’s modulus and 
slope are exceptionally high in the case of the hydrogels after freeze-drying and re-
wetting than straight after 3D bioprinting. Fastly thinking, these are slightly surprising 
results, because freeze-drying shrinks the hydrogels and seems to deteoriorate them 
by changing the shape and the surface of these hydrogels. However, it is true that the 
freeze-dried hydrogels together with the freeze-dried and re-wetted hydrogels feel 
tougher and stiffer when touched in comparison to the 3D bioprinted hydrogels. 
According to the Figure 41, the hydrogels after freeze-drying and re-wetting are less 
pressed, which is also an indication of a stronger material.     
After a literature search, the freeze-drying results are reasonable. According to 
Sornkamnerd et al. (2017), the addition and existence of pores in the lateral direction 
in the hydrogels increases the hydrogel strength. One of the simplest methods for 
  
forming these pores is freeze-drying that constructs anisotropic pores on the side 
faces of the water-swollen, layered hydrogels, but not on the top or bottom faces of 
these hydrogels (Sornkamnerd et al., 2017). The formation of pores is probably due 
to the ice crystals, which make the material accumulate into the areas between them 
(Shao et al., 2015), whereas the fibres are oriented in the tightly packed lamellar 
direction (Shao et al., 2015), increasing the mechanical strength of the hydrogels. The 
mechanical strength is also increased due to the different moisture content of the 
hydrogels, because an aqueous environment is known to decrease the mechanical 
strength (Si et al., 2017), and freeze-drying removes the water from the hydrogels. 
Another reason is the amount of cross-linking in the hydrogels, the bigger amount of 
cross-linking leading to the formation of larger crystal templates and therefore, larger 
pores upon freeze-drying (Hossen et al. 2018).  
As a conclusion, the rough feeling and the small irregularities on the side faces of the 
freeze-dried hydrogels in this Master’s thesis have most probably been due to pores, 
and thus, it is natural that the freeze-dried and re-wetted hydrogels of the present 
work are stronger and stiffer when compared to the hydrogels measured straight 
after 3D bioprinting. Furthermore, as explained earlier, the addition of CLPs starts 
more and more to interfere the hydrogen bonds between the CNF fibres, which in 
turns increases the mobility of the hydrogel material, increasing the number and size 
of the pores upon freeze-drying, and further increasing the mechanical strength of 
the freeze-dried and re-wetted hydrogels.    
 
 
 
 
 
 
 
 
  
APPENDIX 6. 
Equation (2) for the Young’s modulus, E, and calculations for the E and slope, k, in 
the DMA.   
 
𝐸 =  
𝐹 ∗ 𝐿0
∆𝐿 ∗ 𝐴
                                                                                                                           (2) 
 
Table 23. The values used in the calculations of E and k of the 3D bioprinted hydrogels. 
 CNF-alginate 1% CLPs-CNF-
alginate 
5% CLPs-CNF-
alginate 
10% CLPs-CNF-
alginate 
25% CLPs-CNF-
alginate 
F (N) 0.0849 4.3200 0.1410 274.9956 101.911 
K 0.0006 7.1429 2.9375 208.93 102.94 
∆L (m)  0.0074 0.6048 0.477 1.32 0.99 
L0 (m) 0.01 0.012 0.009 0.01 0.01 
A (m2) 0.0007 0.0007 0.0007 0.0007 1.0007 
E (N/m2) 0.08 121.2 37.4 2946.7 1456.0 
 
Table 24. The values used in the calculations of E and k of the re-wetted and freeze-dried hydrogel.  
 CNF-alginate 1% CLPs-CNF-
alginate 
5% CLPs-CNF-
alginate 
10% CLPs-CNF-
alginate 
25% CLPs-CNF-
alginate 
F (N) 89.999 119.999 140 1200 130 
K  391.3 545.45 388.89 6000 1625 
∆L (m) 0.23 0.22 0.36 0.002 0.008 
L0 (m) 0.01 0.01 0.01 0.01 0.01 
A (m2) 0.0003 0.0003 0.0003 0.0005 0.0004 
E (N/m2) 1.3*106 1.8*106 1.3*106 133.3*106 4.3*106 
 
 
 
 
 
 
 
 
 
 
 
  
APPENDIX 7.  
Evaluation of the best hydrogels.  
 
Table 25. Comparison of the performance of the different hydrogel compositions in the various measurement 
conditions. The best hydrogel in the case of each measurement condition has a colour of red, and the second best 
the colour of blue. The winners have been highlighted with the red square.     
Figure 42. Comparison of the dimensional changes of the different hydrogel compositions in various storage 
conditions. Hydrogels with CLP concentrations of 10% and 25% always react approximately the most which results 
in the change in dimensions. On the other hand, hydrogels with the concentrations of 1% and 5% react 
approximately the least despite the storage method. 
 
